EnSync, Inc. (Form: DEF 14A, Received: 10/10/2018 17:00:08)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

Filed by the Registrant x

Filed by a Party other than the Registrant ¨

Check the appropriate box:

¨ Preliminary Proxy Statement

¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

x Definitive Proxy Statement

¨ Definitive Additional Materials

¨ Soliciting Material Pursuant to Rule 14a-12

ENSYNC, INC.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)

Title of each class of securities to which transaction applies: N/A

(2)

Aggregate number of securities to which transaction applies: N/A

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): N/A

(4)

Proposed maximum aggregate value of transaction: N/A

(5)

Total fee paid: N/A

Fee paid previously with preliminary materials.

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount Previously Paid: N/A

(2)

Form, Schedule or Registration Statement No.: N/A

(3)

Filing Party: N/A

(4)

Date Filed: N/A

EnSync, Inc.

N88 W13901 Main Street, Suite 200

Menomonee Falls, Wisconsin 53051

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

TO BE HELD ON NOVEMBER 13, 2018

Dear Shareholder:

You are cordially invited to attend the annual meeting of shareholders of EnSync, Inc. to be held at the Radisson Hotel, N88 W14750 Main St., Menomonee Falls, Wisconsin 53051, on Tuesday, November 13, 2018 at 10:00 a.m., local time. At the 2018 Annual Meeting, shareholders will be asked to:

elect the one Class II director nominated by the Board of Directors for a three-year term;

vote, on a non-binding advisory basis, on the compensation paid to our named executive officers;

approve an amendment to the 2010 Omnibus Long-Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 5,000,000 shares;

approve an amendment to the 2012 Non-Employee Director Equity Compensation Plan to increase the number of shares reserved for issuance thereunder by 2,000,000 shares; and

ratify the appointment of Baker Tilly Virchow Krause, LLP as our independent registered public accounting firm.

On or about October 10, 2018, we will mail to each of our shareholders paper copies of our proxy statement and annual report for fiscal 2018. The proxy materials contain this formal notice to each of our shareholders of our upcoming annual meeting. Details regarding the meeting and the business to be conducted are described in the accompanying proxy statement. In addition to considering the matters described in the proxy statement, we will report on matters of interest to our shareholders.

We look forward to your attending either in person or by proxy. Your vote is important, and I hope that you will vote as soon as possible by following the voting instructions set forth in the enclosed proxy materials.

If you have any questions or require any assistance with completing your proxy, please contact Kingsdale Advisors by telephone (toll-free within North America) at 1-866-851-4179 or (call collect outside North America) at 416-867-2272 or by email at contactus@kingsdaleadvisors.com

	Very truly yours,

	/s/Bradley L. Hansen
	Bradley L. Hansen
	Chief Executive Officer and President

October 10, 2018

EnSync, Inc.

N88 W13901 Main Street, Suite 200

Menomonee Falls, Wisconsin 53051

PROXY STATEMENT

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2018 ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON NOVEMBER 13, 2018

The notice of the annual meeting of shareholders and proxy statement are available at:

http://www.envisionreports.com/ESNC

EnSync, Inc. and its subsidiaries. Our fiscal year ends on June 30 of each year. In this proxy statement, we refer to fiscal years by reference to the calendar year in which they end (e.g., the fiscal year ended June 30, 2018 is referred to as “fiscal 2018”).

The enclosed proxy is solicited by the Board of Directors of EnSync, Inc. for use at the Annual Meeting of Shareholders to be held on Tuesday, November 13, 2018 at 10:00 a.m., local time, or at any postponement or adjournment of the annual meeting, for the purposes set forth in this proxy statement and in the accompanying notice of annual meeting of shareholders. The annual meeting will be held at the Radisson Hotel, N88 W14750 Main St., Menomonee Falls, Wisconsin.

The expenses of printing and mailing proxy materials, including expenses involved in forwarding materials to beneficial owners of stock, will be paid by us.

Our Board of Directors recommends that our shareholders vote their shares:

“ FOR ” the one Class II director nominated by the Board of Directors to serve until the 2021 annual meeting of shareholders;

“ FOR ” the approval, on a non-binding advisory basis, of the proposal regarding the compensation paid to our named executive officers;

“ FOR ” the proposal to amend the 2010 Omnibus Long-Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 5,000,000 shares;

“ FOR ” the proposal to amend the 2012 Non-Employee Director Equity Compensation Plan to increase the number of shares reserved for issuance thereunder by 2,000,000 shares; and

“ FOR ” the ratification of the appointment of Baker Tilly Virchow Krause, LLP (“Baker Tilly”) as our independent registered public accounting firm.

Only shareholders of record at the close of business on September 27, 2018 are entitled to notice of and to vote at the annual meeting. As of the record date, there were 68,014,385 shares of common stock, $0.01 par value per share and 2,300 shares of series B convertible preferred stock, $0.01 par value per share issued and outstanding and entitled to vote at the annual meeting. Each holder of our common stock is entitled to one vote for each share of our common stock held as of the close of business on the record date, and each holder of our series B convertible preferred stock is entitled to one vote for each share of our common stock issuable upon conversion of our series B convertible preferred stock held as of the close of business on the record date. As of the record date, each share of our series B convertible preferred stock was convertible into 1,725 shares of common stock. Accordingly, each share of our series B convertible preferred stock is entitled to 1,725 votes on each matter presented at the annual meeting.

Based on an Amendment No. 6 to Schedule 13D jointly filed with the Securities and Exchange Commission (“SEC”) on July 12, 2017 (the “Schedule 13D”) by (i) Melodious Investments Company Limited, a British Virgin Islands Company (“MICL”) and wholly owned subsidiary of Melodious International Investments Group Limited (“MIIGL”), (ii) MIIGL, a British Virgin Islands company wholly owned by Jilun He, and (iii) Jilun He, who is the sole director of both MICL and MIIGL (together with MICL and MIIGL, the “Reporting Persons”), the Reporting Persons indicated they shared power to vote or direct the vote of 8,000,000 shares of the Company’s Common Stock as of such filing date. In addition, as of the record date, Jilun He has the sole power to vote or direct the vote of 8,550,993 shares of the Company’s common stock and has the sole power to dispose or to direct the disposition of 8,550,993 shares of the Company’s common stock. As of the record date, however, due to the provisions of the Wisconsin Business Corporation Law (the “WBCL”) described below, the voting power of the Reporting Persons at the annual meeting will be limited to 14,611,780 votes. This amount represents approximately 20.9% of the outstanding shares of common stock as of the record date. Under the WBCL and the control share voting restrictions provided therein, the voting power of shares of a Wisconsin corporation held by any person or persons “acting as a group for the purpose of acquiring or holding securities” (including shares issuable upon conversion of convertible securities or upon exercise of options or warrants) in excess of 20% of the voting power in the election of directors is limited to 10% of the full voting power of those shares. This voting restriction applies to shareholders of a Wisconsin corporation unless such corporation has affirmatively provided otherwise in its articles of incorporation or another exemption applies. These control share voting restrictions are applicable to the Reporting Persons because the Company has not affirmatively opted out of such restrictions in its articles of incorporation and no other exemption applies. In addition, under the WBCL and the business combination restrictions provided therein, a Wisconsin corporation may not complete a business combination (generally defined as a merger or share exchange) with a person who is the beneficial owner of 10% or more of the voting power of the corporation’s outstanding voting stock (an “interested stockholder”) within three years following the date of the share acquisition that caused the person to become an interested stockholder, unless the corporation’s board of directors approved such share acquisition before it took place. Because the Company’s board of directors did not approve the Reporting Persons’ acquisition of shares of the Company’s common stock, these restrictions would apply to any potential business combination involving the Reporting Persons.

The presence, in person or by proxy, of one-third of the total votes entitled to be cast on each matter at the annual meeting will constitute a quorum at the annual meeting. Abstentions and broker non-votes, which are proxies from brokers or nominees indicating that such persons have not received instructions from the beneficial owners or other persons entitled to vote shares as to a matter with respect to which brokers or nominees do not have discretionary power to vote, will be treated as present for purposes of determining the quorum.

Directors are elected by a plurality of the votes cast by shareholders entitled to vote at the annual meeting, which means the nominee receiving the most affirmative votes will be elected. On all other matters, an affirmative vote of at least a majority of the votes cast is required for approval.

The holders of the shares of our common stock and series B convertible preferred stock issued and outstanding as of the record date will vote together, on a combined basis, on each matter to be presented at the annual meeting.

Banks, brokers and other holders of record do not have discretionary authority to vote shares held in street name in connection with non-routine proposals, which include all the proposals other than the ratification of the appointment of Baker Tilly as our independent registered public accounting firm. As a result, broker non-votes will occur at the 2018 Annual Meeting with respect to only these non-routine proposals. However, since broker non-votes are not counted as votes cast they will have no effect on the outcome of these proposals.

Banks, brokers and other holders of record have discretionary authority to vote shares held in street name, even if they do not receive instructions from the beneficial owner, on routine proposals, which includes the ratification of the appointment of an independent registered public accounting firm. Accordingly, if you do not provide your bank, broker or other holder of record with voting instructions with respect to this proposal, such holder will have discretionary authority to vote your shares held in street name on this proposal at the 2018 Annual Meeting. As a result of this discretionary authority, broker non-votes are not expected to occur in connection with Proposal 5 at the annual meeting.

We are mailing printed copies of this proxy statement, our Annual Report to Shareholders, and other proxy materials to our shareholders on or about October 10, 2018. These proxy materials contain the formal Shareholder Meeting Notice for the 2018 Annual Meeting (the “Notice”) and instructions as to how shareholders may submit proxies by telephone or over the internet.

If a proxy is granted properly by using the internet or telephone procedures specified in the proxy materials or a proxy card is properly signed and returned to us and not revoked, it will be voted in accordance with the instructions given. Each shareholder may revoke a previously granted proxy at any time before it is exercised by using the internet or telephone procedures specified in the proxy materials or by submitting written notice of revocation or a duly executed proxy bearing a later date to us. Attendance at the annual meeting will not, in itself, constitute revocation of a proxy but a shareholder in attendance may request a ballot and vote in person, which revokes a prior granted proxy. Where a proxy is properly signed and returned without indicating any voting instructions regarding a proposal, the shares represented by the proxy will be voted in the manner recommended by the Board of Directors on all matters presented in this proxy statement.

The Board of Directors knows of no other matters to be presented at the annual meeting. If any other matter should be presented at the annual meeting, the proxy holders may vote any shares represented by proxy in their discretion.

The expenses of printing and mailing proxy materials, including expenses involved in forwarding materials to beneficial owners of stock, will be paid by us.

Voting Procedures

Registered Shareholders

If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, you are considered the “shareholder of record” with respect to those shares, and we have sent the Notice directly to you. As a shareholder of record, you have the right to grant your voting proxy directly to us or to a third party, or to vote in person at the 2018 Annual Meeting.

Registered shareholders who are unable to be present at the 2018 Annual Meeting should exercise their right to vote by signing and returning the form of proxy, or voting via the internet or telephone, in accordance with the directions on the form. Computershare Investor Services Inc. must receive completed proxies no later than 5:00 p.m. (Central time) on November 12, 2018.

Non-registered shareholders

If your shares are held in a brokerage account or by a bank or nominee, you are considered non-registered or the “beneficial owner” of shares held in “street name,” and the Notice is being forwarded to you by your broker, bank or nominee (who is considered the shareholder of record with respect to those shares). As the beneficial owner, you have the right to direct your broker, bank or nominee how to vote your shares. Your broker, bank or nominee has enclosed or provided voting instructions for you to use in directing the broker, bank or nominee how to vote your shares. You are also invited to attend the 2018 Annual Meeting. However, because you are not the shareholder of record, you may not vote your shares in person at the 2018 Annual Meeting unless you obtain a “legal proxy” from your broker, bank or nominee giving you the right to vote the shares at the 2018 Annual Meeting.

By Internet – Shareholders of record with Internet access may submit proxies until 5:00 p.m., Central time, on November 12, 2018, by following the instructions at www.proxyvote.com. Most EnSync shareholders who hold shares beneficially in street name may vote by accessing the website specified in the voting instructions provided by their brokers, trustees or nominees. If you are a beneficial owner, please check the voting instructions provided by your broker, trustee or nominee for information regarding Internet voting availability.

By Telephone – If this option is available to you, you will have received information with the Notice or the voting instructions provided by your broker, bank or nominee explaining this procedure.

Broadridge or your intermediary, as applicable, must receive your voting instructions at least one business day in advance of the proxy deposit date noted on your voting instruction form. If a non-registered shareholder wishes to attend and vote at the Meeting in person (or have another person attend and vote on the shareholder’s behalf), the shareholder must complete the voting instruction form in accordance with the appointee directions provided.

EnSync may use the Broadridge QuickVote™ service to assist beneficial shareholders with voting their shares over the telephone. Alternatively, Kingsdale Advisors (“Kingsdale”) may contact such beneficial shareholders to assist them with conveniently voting their shares directly over the phone. If you have any questions about the Meeting, please contact Kingsdale by telephone at 1-866-851-4179 (toll-free in North America) or 1-416-867-2272 (collect outside North America) or by email at contactus@kingsdaleadvisors.com.

SECURITIES OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information regarding beneficial ownership of our common stock as of September 27, 2018 by:

each person or group of affiliated persons known by us to be the beneficial owner of more than 5% of our common stock;

each executive officer included in the Summary Compensation Table below;

each of our directors;

each person nominated to become director; and

all executive officers, directors and nominees as a group.

Unless otherwise noted below, the address of each person listed on the table is c/o EnSync, Inc. at N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051. To our knowledge, and subject to applicable community property laws, each person listed below has sole voting and investment power over the shares shown as beneficially owned except to the extent jointly owned with spouses or otherwise noted below.

Beneficial ownership is determined in accordance with the rules of the SEC. The information does not necessarily indicate ownership for any other purpose. Under these rules, a person is deemed the beneficial owner of a security if that person has the right to acquire beneficial ownership of such security within 60 days after September 27, 2018, including the right to acquire shares of common stock subject to options or convertible preferred stock. Shares of common stock subject to options that may be exercised within 60 days after September 27, 2018 are deemed to be beneficially owned and outstanding for purposes of calculating the number of shares and the percentage of common stock beneficially owned by the shareholder holding the options, but are not deemed to be beneficially owned and outstanding for purposes of computing the percentage beneficially owned by any other person. The applicable percentage of common stock outstanding as of September 27, 2018 is based upon 68,014,385 shares outstanding on that date.

	Amount and Nature of Beneficial Ownership
Name of Beneficial Owner	Common Stock			Shares Underlying Convertible Preferred Stock, Restricted Stock Units and Options (1)			Total		Percentage of Class
Directors, Nominees and Executive Officers
Richard A. Abdoo		1,637,411	⁽²⁾		431,216			2,068,627		3.0	%
Manfred E. Birnbaum		407,960			-			407,960		*
William Dallapiazza		-			-			-		*
Kevin A. Dennis		7,262			710,748			718,010		1.0	%
Bradley L. Hansen		165,950			360,000			525,950		*
Paul F. Koeppe		2,387,593			471,215			2,858,808		4.2	%
Daniel A. Nordloh		4,000			671,000			675,000		*
James H. Ozanne		80,362			15,000			95,362		*
Theodore Stern		1,594,074	⁽³⁾		1,813,530	⁽⁴⁾		3,407,604		4.9	%
Directors, Nominees and Executive Officers as a group (9 persons)		6,284,612			4,472,709			10,757,321		14.8	%

Five Percent Stockholders
Melodious Investments Company Limited ⁽⁵⁾		16,550,993			-			16,550,993		24.3	%

Less than one percent.

(1)

Includes: (i) shares of common stock issuable upon the exercise of stock options exercisable within 60 days of September 27, 2018; (ii) shares of common stock underlying shares of series B convertible preferred stock convertible within 60 days of September 27, 2018 and (iii) shares of common stock underlying vested restricted stock unit awards issuable within 60 days of September 27, 2018. Does not include shares of common stock issuable upon the exercise of stock options not exercisable within 60 days of September 27, 2018. Also does not include shares of common stock underlying vested restricted stock unit awards that are issuable following separation from service as follows: Richard Abdoo (809,496 shares); Manfred Birnbaum (400,415 shares); Bradley Hansen (1,020,000 shares); Paul Koeppe (913,283 shares); James Ozanne (762,589 shares); and Theodore Stern (203,640 shares).

(2)

855,013 of these shares are held by Richard A. & Joan F. Abdoo Trust Dtd 9/8/2006 and 633,541 are held by R.A. Abdoo & Co., LLC. Mr. Abdoo shares voting and dispositive power over these shares.

(3)

617,187 of these shares are held by Bomoseen Associates, LP and 192,308 are held by Theodore Stern Revocable Trust. Mr. Stern shares voting and dispositive power over these shares.

(4)

Includes shares underlying shares of series B convertible preferred stock held by Bomoseen Associates, LP. Mr. Stern shares voting and dispositive power over these shares.

(5)

Consists of 16,550,993 shares beneficially owned by MICL, a wholly owned subsidiary of MIIGL, which is wholly owned by Jilun He, who is the sole director of both MICL and MIIGL. Jilun He has the sole power to vote or to direct the vote of 8,550,993 shares and has the sole power to dispose or to direct the disposition of 8,550,993 shares. Each of MICL, MIIGL and Jilun He have the shared power to vote or to direct the vote of 8,000,000 shares and have the shared power to dispose or to direct the disposition of 8,000,000 shares. The principal business address of each of MICL, MIIGL and Jilun He is Sea Meadow House, Blackburne Highway, (P.O. Box 116), Road Town, Tortola, British Virgin Islands. This information has been obtained from an Amendment No. 6 to Schedule 13D jointly filed by MICL, MIIGL and Jilun He with the SEC on July 12, 2017.

PROPOSAL 1—ELECTION OF DIRECTORS

The Company’s Board of Directors currently consists of five members and is divided into three classes serving terms of three years. Shareholders elect one class of directors at each annual meeting. There are two directors in the class whose term of office expires in 2018: Richard A. Abdoo and Manfred L. Birnbaum. Mr. Birnbaum will not be standing for reelection. Accordingly, one director is to be elected at this annual meeting to hold office until the 2021 annual meeting of shareholders or until a successor has been duly elected and qualified. Upon the recommendation of the Nominating/Governance Committee of our Board of Directors, the Board of Directors has nominated and recommended, Mr. Abdoo for election to the Board of Directors as a Class II director.

Shares represented by all proxies received by the Board of Directors and not marked so as to withhold authority to vote for any individual nominee will be voted “ FOR ” the election of the nominee named below. The Board of Directors knows of no reason why such nominee would be unable or unwilling to serve, but if such should be the case, proxies may be voted for the election of some other person nominated by the Board of Directors.

Election of the directors requires the affirmative vote of a plurality of the votes cast by the holders of our common stock and series B convertible preferred stock, voting together on a combined basis. Accordingly, the director nominee receiving the most affirmative votes will be elected. An abstention or broker non-vote will have no effect on the outcome of the election of directors.

THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE “FOR” THE NOMINEE LISTED BELOW

Information Concerning Directors and Nominee for Director

The following table sets forth the nominee to be elected at the annual meeting and continuing directors and, for each nominee and director whose term of office will extend beyond the annual meeting, the year such director was first elected as a director, the positions currently held by each director with us, the year each director’s current term will expire and the current class of each director.

Nominee’s or Director’s Name and Year First Became Director	Age	Position with the Company	Year Current Term Will Expire	Current Class of Director
Nominee for Class II Directors:

Richard A. Abdoo	74	Director	2018	II

Continuing Directors:

Paul F. Koeppe 2009	69	Chairman and Director	2019	III

Theodore Stern 2014	89	Director	2019	III

Bradley L. Hansen 2014	56	President, Chief Executive Officer and Director	2020	I

James H. Ozanne 2011	75	Director	2020	I

Set forth below is background information for each current director and nominee for director, as well as information regarding additional experience, qualifications, attributes or skills that led the Board of Directors to conclude that such director or nominee should serve on the Board of Directors.

Richard A. Abdoo is president of R.A. Abdoo & Co. LLC, an environmental and energy consulting firm. Prior to starting this business, he was chairman and chief executive officer of Wisconsin Energy Corporation (NYSE: WEC) from 1991 until his retirement in 2004. He also served as President from 1991 to 2003 and joined the company in 1975 as Director of Strategic Planning. During his administration, Wisconsin Energy Corporation grew to become a Fortune 500 company through a series of mergers and acquisitions. Mr. Abdoo previously served as a director of Renegy Holdings, Inc., M&I Marshall & Ilsley Corporation, AK Steel (NYSE: AKS), a steel products producer and NiSource Inc. (NYSE: NI), a natural gas and electric generation and distribution company. He is currently a member of St. Jude’s Children’s Research Hospital’s Professional Advisory Board, a registered professional engineer in Michigan, Ohio, Pennsylvania and Wisconsin, and a longtime member of the American Economic Association. In 2000, Mr. Abdoo was awarded the Ellis Island Medal of Honor, presented to Americans of diverse origins for their outstanding contributions to their own ethnic groups and to American society. Honorees typically include U.S. presidents, Nobel Prize winners and leaders of industry. Mr. Abdoo received a Master of Arts degree in Economics from University of Detroit and a Bachelor of Science degree in Electrical Engineering from University of Dayton.

Mr. Abdoo’s extensive knowledge of the energy and energy services industries, and his extensive experience serving on the boards of directors of other companies qualify him to serve as a member of our Board of Directors.

Paul F. Koeppe has served as our Chairman since September 2010. Mr. Koeppe was President, CEO and founder of Superconductivity, Inc., a manufacturer of superconducting magnetic energy storage systems, from 1988 to 1997 when it was acquired by American Superconductor Corp. (Nasdaq: AMSC), an electricity solutions company. He then served as Executive Vice President of Strategic Planning for American Superconductor Corp. until his retirement in 2001. From 1993 to 1995, Mr. Koeppe was acting CEO and chairman of the executive committee of the board of directors of Best Power, Inc., a supplier of uninterruptible power supply equipment. Mr. Koeppe previously served as a director of InContact, Inc. (formerly Nasdaq: SAAS), a software-as-a-service company in Salt Lake City, Utah from 2004 to the company’s acquisition in November 2016. Mr. Koeppe also served as a director of Distributed Energy Systems Corp., from 2003 to 2010 and also as a member of the Board of Directors at Northern Power Systems from 1998 until 2003 when Northern Power Systems was acquired by Distributed Energy Systems Corp. Prior to founding Superconductivity, Inc. Mr. Koeppe worked for Wisconsin Power and Light Company for 15 years in a variety of functions. He has earned a Bachelor of Arts degree in Business Administration from Lakeland College and Associate Degrees in Materials Management and Electrical Power Technology.

Mr. Koeppe’s extensive executive, managerial and leadership experience, including many years in the energy services industry, positions him well to serve as a member of our Board of Directors. His business acumen and experience on the boards of directors of numerous companies make him a valuable addition to our Board of Directors.

Theodore Stern has served in several executive positions in the energy and software industries over his career. Since 2017, Mr. Stern has served as a director of Ipsidy Inc. (OTCQX: IDTY). Formerly, he served as Chairman of the Board of Directors of inContact, Inc., (formerly Nasdaq: SAAS) a software-as-a-service company in Salt Lake City, Utah from April 2000 to the company’s acquisition in November 2016. Mr. Stern also was a Senior Executive Vice President and member of the Board of Directors of Westinghouse Electric Corporation until his retirement. In his last position at Westinghouse Electric Corporation, Mr. Stern was responsible for multiple business units, including Power Generation, Energy Systems and Governmental and Environmental Affairs. The businesses reporting to Mr. Stern totaled more than $3 billion in annual revenue and 50,000 employees. Mr. Stern served as Vice Chairman of the Board of Directors of Superconductivity, Inc. of Madison, WI, a small technology company, until it was acquired in April 1997. Mr. Stern also served on the board of directors of Copperweld Corporation of Pittsburgh, PA, a privately-owned steel and cable manufacturer, until its acquisition by LTV Corp. Mr. Stern also served on the board of directors of Northern Power Systems of Waitsfield, VT, a privately-owned manufacturer of renewable and distributed generation systems, until it was acquired by Distributed Energy Systems Corp. Mr. Stern also served on the board of directors of Distributed Energy Systems Corp. Mr. Stern holds a Bachelor of Science degree in Mechanical Engineering from the Pratt Institute and a Master of Arts degree in Theoretical Mathematics from New York University. He is a fellow of the American Society of Mechanical Engineers and a member of the National Academy of Engineering. He is the author of a number of technical papers on nuclear power technology.

Mr. Stern brings his over 25 years of experience serving as a director with public companies to our Board of Directors. This experience, which includes service as chairman and as a member of audit, compensation and governance committees, provides our Board of Directors with a valuable perspective regarding public company governance, corporate management and strategy, and board practices.

Bradley L. Hansen has served as our President and Chief Executive Officer since July 2015. Mr. Hansen served as our President and Chief Operating Officer from May 2014 to July 2015. Since December 2011, Mr. Hansen has also served as the Chief Executive Officer of Anhui Meineng Store Energy Co., Ltd. (“Meineng”), our China joint venture company, where he has led Meineng’s organization and development. In 2010, Mr. Hansen founded and continues to serve as Managing Partner of PowerSav Inc., a boutique private equity fund targeting China government policy supported markets. Mr. Hansen has extensive expertise in the international renewable energy and semiconductor industries, having held various executive positions with Applied Materials, Inc. (Nasdaq: AMAT) from 1989 to 2010. While at Applied Materials, Inc., Mr. Hansen led global sales and site operation organizations for its solar product line, an important growth driver for the company. Prior to this role, Mr. Hansen directed the acquisition and integration activities for Applied Materials, Inc.’s strategic Applied Film Corporation (formerly Nasdaq: AFCO). Mr. Hansen also held a number of key product development and operations roles at Applied Materials, Inc., including Vice President and General Manager of the Chemical Mechanical Planarization Product Business Group. Prior to Applied Materials, Inc., Mr. Hansen worked as an Engineer and Program Manager for the Boeing Electronics Company Division of The Boeing Company (NYSE: BA). Mr. Hansen holds a Bachelor of Science degree in Manufacturing Engineering from Brigham Young University and an MBA from Seattle University.

Mr. Hansen brings to the Board of Directors deep knowledge of the Company’s industry and markets and broad management and business experience, including extensive experience doing business in China.

James H. Ozanne has served in executive and director positions in the financial services industries since 1972. During this time he has held the positions of Chief Financial Officer, President, Chief Executive Officer and Chairman of several leasing, rental, and consumer finance businesses ranging from full service railcar leasing to general equipment finance and grocery pallet rental. He was President and Chief Executive Officer of Nation Financial Holdings and its predecessor, US WEST Capital. Prior to that, he served as Executive Vice President of GE Capital responsible for the Consumer Finance and Operating Lease/Asset Management business units. Mr. Ozanne was a director of United Rentals, Inc. (NYSE: URI), the largest equipment rental company in the world, and is a director of NMI Holdings, Inc. (Nasdaq: NMIH). Previously, Mr. Ozanne was Lead Independent Director of RSC Holdings Inc., a director of Financial Security Assurance Holdings Ltd. and Distributed Energy Systems Corp., Vice Chairman and director of Fairbanks Capital Corp. and Chairman of Source One Mortgage Corporation. Mr. Ozanne received a Bachelor of Science degree from DePaul University.

Mr. Ozanne brings financial and management expertise to our Board of Directors acquired through his experience as a chief financial officer and as an operating executive. He also possesses valuable director experience from having served on the boards of directors of numerous companies, including in the roles of chairman and lead independent director.

Information Concerning Executive Officers

Set forth below is background information relating to our executive officers:

Name	Age	Position
Bradley L. Hansen	56	Chief Executive Officer and President
William J. Dallapiazza	45	Chief Financial Officer and Secretary
Daniel A. Nordloh	52	Executive Vice President of Global Business Development
Kevin A. Dennis	55	Vice President of Engineering and Product Development

Bradley L. Hansen is discussed above under Information Concerning Directors and Nominee for Director .

William J. Dallapiazza joined the Company as Interim Vice President of Finance in July 2017 and was appointed Chief Financial Officer in February 2018. From January 2014 to April 2017, Mr. Dallapiazza served as Vice President and Controller for Franklin Energy Services, an implementer of energy efficiency and educational programs for utilities, municipalities and state partnerships. From August 2006 to December 2013, he also served as Corporate Controller for RathGibson, a stainless-steel tubing manufacturer, and in various positions with RathGibson's acquirer, Precision Castparts Corp. (formerly NYSE: PCP), a manufacturer of complex metal components and products. From November 2002 to August 2006, he served as Corporate Controller for The Aristotle Corporation (formerly NASDAQ: ARTL), a provider of educational, health, medical, and agricultural products. He holds a BBA in Accounting and Finance from University of Wisconsin-Oshkosh and is a Certified Public Accountant in Wisconsin.

Daniel A. Nordloh joined the Company as Vice President of Sales, Marketing and Business Development in April 2010 and was appointed Executive Vice President of Global Business Development in November 2011. From August 2007 to April 2010, Mr. Nordloh served as Principle of Synapse Junction, LLC, a boutique advisory practice founded to assist early stage and established companies with effective growth planning and execution initiatives. In his role at Synapse Junction, LLC, Mr. Nordloh served in numerous leadership roles, including interim President and CEO of a technology company on behalf of a private equity group. From August 2005 to August 2007, Mr. Nordloh served as President and CEO of Naviant, Inc. (formerly MTM International), a consulting and technology firm. Mr. Nordloh presently serves on the Board of Directors of Meineng, our China joint venture company, and the Board of Directors of Standard Imaging Inc. Mr. Nordloh previously served as President of the Board of the not-for-profit Family Support & Resource Center of Dane County, WI. He earned an MBA from the University of Wisconsin-Milwaukee and a BS degree in Behavioral Sciences from Eastern Kentucky University.

Kevin A. Dennis joined the Company as Vice President of Marketing and Sales in January 2008 and was appointed Vice President of Engineering and Product Development in 2010. Mr. Dennis has extensive expertise in the utility and renewable energy markets having held various engineering, sales and senior management roles with ABB (NYSE:ABB), a power and automation technologies company, most recently as Director, Advanced Power Electronics – North America. He also spent four years as both the sales and engineering manager for Omnion Power Engineering Corporation, a manufacturer of power electronics systems for advanced energy systems. His early career also includes five years as a design engineer with American Electric Power Service Corporation. He holds a Bachelor of Science degree in Electrical Engineering from Michigan Technological University, is a registered professional engineer in the State of California and is a member of the IEEE (Power Electronics Group). He participated as an industry representative in the working group for the development of Underwriters Laboratory standard, UL 741, for utility grid connected power converters. He also participates in various renewable energy and energy storage organizations.

Corporate Governance Principles and Board Matters

Board Independence

The Board of Directors has determined that each of James H. Ozanne, Richard A. Abdoo, Manfred E. Birnbaum, Paul F. Koeppe and Theodore Stern is an independent director within the meaning of the director independence standards of NYSE American (“NYSE American”). Furthermore, the Board of Directors has determined that all of the members of the Audit Committee, Compensation Committee and Nominating/Governance Committee are independent within the meaning of the director independence standards of NYSE American and the rules of the SEC applicable to each such committee.

Board Leadership Structure

The Board of Directors has an independent chairman, meaning that the positions of chairman of the Board of Directors and Chief Executive Officer are not held by a single individual. The Board of Directors believes that having an independent chairman ensures that management is subject to independent and objective oversight and the independent directors have an active voice in the governance of the Company.

Executive Sessions of Independent Directors

Executive sessions of our independent directors are generally held following each regularly scheduled in-person meeting of the Board of Directors. Executive sessions do not include any non-independent directors and are led by the chairman of the Board of Directors, who is independent. The independent directors of the Board of Directors met in executive session three times in fiscal 2017.

Policies Regarding Director Nominations

Director Qualifications

The Nominating/Governance Committee is responsible for identifying the appropriate qualifications, skills and characteristics desired of members of the Board of Directors in the context of the needs of the business and the current composition and needs of the Board of Directors.

Director candidates are considered based upon a variety of criteria, including demonstrated business and professional skills and experiences relevant to our business and strategic direction, concern for long-term shareholder interests, personal integrity and sound business judgment. The Board of Directors seeks men and women from diverse professional backgrounds who combine a broad spectrum of relevant industry and strategic experience and expertise that, in concert, offer us and our shareholders diversity of opinion and insight in the areas most important to us and our corporate mission. In addition, nominees for director are selected to have complementary, rather than overlapping, skill sets. However, the Nominating/Governance Committee does not have a formal policy concerning the diversity of the Board of Directors. All candidates for director nominee must have time available to devote to the activities of the Board of Directors. The Nominating/Governance Committee also considers the independence of candidates for director nominee, including the appearance of any conflict in serving as a director. Candidates for director nominees who do not meet all of these criteria may still be considered for nomination to the Board of Directors, if the Nominating/Governance Committee believes that the candidate will make an exceptional contribution to us and our shareholders.

Process for Identifying and Evaluating Director Nominees

The Board of Directors is responsible for selecting its own members. The Board of Directors delegates the selection process to the Nominating/Governance Committee, with the expectation that other members of the Board of Directors, and of management, may be requested to take part in the process as appropriate. Generally, the Nominating/Governance Committee identifies candidates for director nominees in consultation with management, through the recommendations submitted by other directors or shareholders or through such other methods as the Nominating/Governance Committee deems appropriate. Once candidates have been identified, the Nominating/Governance Committee confirms that the candidates meet the qualifications for director nominees established by the Nominating/Governance Committee. The Nominating/Governance Committee may gather information about the candidates through interviews, detailed questionnaires, comprehensive background checks, or any other means that the Nominating/Governance Committee deems to be helpful in the evaluation process. The Nominating/Governance Committee then meets as a group to discuss and evaluate the qualities and skills of each candidate, both on an individual basis and taking into account the overall composition and needs of the Board of Directors. Based on the results of the evaluation process, the Nominating/Governance Committee recommends candidates for the Board of Directors’ approval as director nominees for election to the Board of Directors.

Policy for Recommendation of Director Nominees by Shareholders

The policy of the Nominating/Governance Committee is to consider properly submitted shareholder recommendations for director candidates in accordance with our Policies Regarding Recommendation of Director Candidates. Under our policy, recommendations for director candidates other than those made by the Board of Directors or the Nominating/Governance Committee must be made pursuant to timely notice in proper written form to the secretary of EnSync. To be timely, a shareholder’s recommendation of a candidate for election to the board at an annual meeting of shareholders, together with the written consent of such person to serve as a director, must be received by the secretary of EnSync not more than 120 days before the date our proxy statement was released to shareholders in connection with the previous year’s annual meeting. To be in proper written form, the notice must contain certain information concerning the nominee and the shareholder submitting the nomination and include:

the name and address of the shareholder submitting the recommendation, the beneficial owner, if any, on whose behalf the recommendation is made and the director candidate;

the class and number of shares of our stock that are owned beneficially and of record by the shareholder and, if applicable, the beneficial owner, including the holding period for such shares as of the date of the recommendation;

full biographical information concerning the director candidate, including a statement about the director’s qualifications;

all other information regarding each director candidate proposed by such shareholder as would be required to be included in a proxy statement filed pursuant to the proxy rules of the SEC;

description of all arrangements or understandings among the shareholder and the candidate and any other person or persons pursuant to which the recommendation is being made;

description of all relationships between the candidate and any of our competitors, customers, suppliers, labor unions or other persons with special interests regarding us; and

a written consent of the candidate to be named in our proxy statement and stand for election if nominated by the Board of Directors and to serve if elected by the shareholders.

Recommendations must be sent to the Chairman of the Nominating/Governance Committee c/o the Secretary, EnSync, Inc., N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051. Once the Nominating/Governance Committee receives a recommendation for a director candidate, such candidate will be evaluated in the same manner as other candidates and a recommendation with respect to such candidate will be delivered to the Board of Directors. The submission of a recommendation by a shareholder in compliance with these procedures will not guarantee the selection of the shareholder’s candidate or the inclusion of the candidate in the proxy statement for the annual meeting. A shareholder wishing to formally nominate a candidate (as opposed to recommending a candidate for nomination by the Board as described above) must do so by following the procedures set forth in our Amended and Restated By-Laws (the “Bylaws”).

Policy Governing Director Attendance at Annual Meetings of Shareholders

Our policy is to schedule a regular meeting of the Board of Directors on the same date as our annual meeting of shareholders and, accordingly, directors are encouraged to be present at such shareholder meetings. All of our then-current board members, except for Hoong Khoeng Cheong, attended the 2017 annual meeting of shareholders.

Code of Ethics

Our Board of Directors adopted a Code of Business Conduct. The Code of Business Conduct, in accordance with Section 406 of the Sarbanes Oxley Act of 2002 and Item 406 of Regulation S-K, constitutes our “code of ethics” thereunder. The Code of Business Conduct codifies the business and ethical principles that govern our business.

The Code of Business Conduct is designed, among other things, to deter wrongdoing and to promote:

Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

Compliance with applicable governmental laws, rules and regulations;

The prompt internal reporting of violations of the ethics code to an appropriate person or persons identified in the Code of Business Conduct; and

Accountability for adherence to the Code of Business Conduct.

Our Code of Business Conduct has historically been posted and is available on our website at www.ensync.com . Additionally, this Code of Business Conduct is provided to all directors, officers and all other personnel upon joining the Company, and thereafter from time-to-time to any person, upon request, and without charge. A copy may also be obtained, free of charge, from us upon a request directed to EnSync, Inc., N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051, attention: Investor Relations. We intend to disclose any amendments to or waivers of a provision of the Code of Business Conduct by posting such information on our website available at www.ensync.com or in our public filings with the SEC.

For more corporate governance information, you are invited to access the Corporate Governance section of our website available at www.ensync.com .

The Board of Directors and Its Committees

Board of Directors

Our Bylaws state that the number of directors constituting the entire Board of Directors shall be determined by resolution of the Board of Directors and that the Board of Directors has the authority to increase the number of directors, fill any vacancies on the Board of Directors and to decrease the number of directors to eliminate any vacancies. The number of directors currently fixed by our Board of Directors is seven.

The Board of Directors has standing audit, compensation, and nominating/governance committees. The Board of Directors held six meetings during fiscal 2018. Each director attended at least 75% of the full board meetings and meetings of committees on which he served during fiscal 2018 except for Mr. Abdoo, who was unable to attend a number of meetings due to health reasons. The Board of Directors and each standing committee retains the authority to engage its own advisors and consultants. Each standing committee has a charter that has been approved by the Board of Directors. A copy of each committee charter is available at www.ensync.com . Each committee reviews the appropriateness of its charter annually or at such other intervals as each committee determines.

The following table sets forth the current members of each standing committee of the Board of Directors:

	Audit:	James H. Ozanne (Chairman)
		Richard A. Abdoo
		Manfred E. Birnbaum
		Paul F. Koeppe
		Theodore Stern

	Compensation:	Manfred E. Birnbaum (Chairman)
		Richard A. Abdoo
		Paul F. Koeppe
		James H. Ozanne
		Theodore Stern

	Nominating/Governance:	Richard A. Abdoo (Chairman)
		Manfred E. Birnbaum
		Paul F. Koeppe
		James H. Ozanne
		Theodore Stern

Committees

The Audit Committee (1) reviews, monitors and reports to the Board of Directors on the adequacy of the Company’s financial reporting process and system of internal controls over financial reporting, (2) has the ultimate authority to select, evaluate and replace the independent auditor and is the ultimate authority to which the independent auditors are accountable, (3) provides the audit committee report for inclusion in our proxy statement for our annual meeting of shareholders and (4) establishes procedures for the receipt, retention and treatment of complaints relating to accounting, internal accounting controls or auditing matters and the receipt of confidential, anonymous submissions by employees of concerns regarding questionable accounting or auditing matters. The Audit Committee is required at all times to be composed exclusively of directors who, in the opinion of our Board of Directors, are free from any relationship that would interfere with the exercise of independent judgment as a committee member and who possess an understanding of financial statements and generally accepted accounting principles. We believe that all the members of the Audit Committee are independent directors as required by the listing requirements for the NYSE American. Our Board of Directors has determined that Mr. Ozanne qualifies as an “audit committee financial expert” as defined under Item 407(d) of Regulation S-K. The Audit Committee met four times during fiscal 2018.

The Compensation Committee (1) discharges the responsibilities of the Board of Directors relating to the compensation of our directors and executive officers, including approving individual executive officer compensation, (2) review and recommend to the Board of Directors compensation plans, policies and programs, (3) administers and implements the Company’s incentive compensation plans and equity-based plans, and (4) provides the compensation committee report for inclusion in our proxy statement for our annual meeting of shareholders. The Compensation Committee met six times during fiscal 2018.

The Nominating/Governance Committee (1) recommends to the Board of Directors persons to serve as members of the Board of Directors and as members of and chairpersons for the committees of the Board of Directors, (2) considers the recommendation of candidates to serve as directors submitted the shareholders of the Company, (3) assists the Board of Directors in evaluating the performance of the Board of Directors and the Board committees, (4) advises the Board of Directors regarding the appropriate board leadership structure for the Company, (5) reviews and makes recommendations to the Board of Directors on corporate governance and (6) reviews the size and composition of the Board of Directors and recommends to the Board of Directors any changes it deems advisable. The composition of the Board of Directors should encompass a broad range of skills, expertise, industry knowledge and diversity of opinion. The Nominating/Governance Committee met four times during fiscal 2018.

Shareholder Communications with the Board of Directors

Shareholders wishing to communicate with members of the Board of Directors may direct correspondence to such individuals c/o William J. Dallapiazza, Secretary, N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051.

All communications received in accordance with these procedures will be reviewed by the Secretary of the Company and forwarded to the appropriate director or directors unless such communications are considered, in the reasonable judgment of the Secretary, to be improper for submission to the intended recipient. Examples of shareholder communications that would be considered improper for submission include, without limitation, communications that:

do not relate to the business or affairs of the Corporation or the functioning or constitution of the Board of Directors or any of its committees;

relate to routine or insignificant matters that do not warrant the attention of the Board of Directors;

are advertisements or other commercial solicitations;

are frivolous or offensive; or

are otherwise not appropriate for delivery to directors.

Role of the Board of Directors in Risk Oversight

The Board of Directors administers its risk oversight function directly and through the Audit Committee. The Board of Directors and the Audit Committee regularly discuss with management the Company’s major risk exposures, their potential financial impact on the Company, and the steps taken to monitor and control those risks.

Audit Committee Report

The Audit Committee of the Company has:

reviewed and discussed the audited financial statements for the fiscal year ended June 30, 2018 with management;

discussed with Baker Tilly, our independent auditors, the matters required to be discussed by the Auditing Standard No. 1031, “Communications with Audit Committees,” as adopted by the Public Company Accounting Oversight Board (United States);

received the written disclosures and the letter from Baker Tilly required by Independent Standards Board Standard No. 1, Independence Discussions with Audit Committees ; and

discussed with Baker Tilly the auditors’ independence.

Based on these reviews and discussions, the Audit Committee recommended to the Board of Directors that that the audited financial statements be included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018.

Respectfully submitted by the Audit Committee.

	THE AUDIT COMMITTEE:
	James H. Ozanne, Chairman
	Richard A. Abdoo
	Manfred E. Birnbaum
	Paul F. Koeppe
	Theodore Stern

EXECUTIVE AND DIRECTOR COMPENSATION

Our compensation philosophy is to offer our executive officers compensation and benefits that are competitive and meet our goals of attracting, retaining and motivating highly skilled management, which is necessary to achieve our financial and strategic objectives and create long-term value for our shareholders. We believe the levels of compensation we provide should be competitive, reasonable and appropriate for our business needs and circumstances. The principal elements of our executive compensation program have to date included base salary, and long-term equity compensation in the form of restricted stock or stock options. We believe successful long term Company performance is more critical to enhancing shareholder value than short term results. For this reason and to conserve cash and better align the interests of management and our shareholders, we emphasize long-term performance-based equity compensation over base annual salaries.

Summary Compensation Table For 2018

The following table represents summary information regarding the compensation of each of Bradley L. Hansen, our President and Chief Executive Officer, Daniel A. Nordloh, our Executive Vice President of Global Business Development and Kevin Dennis, our Vice President of Engineering and Product Development (the “named executive officers”), for fiscal 2018 and fiscal 2017.

Name and Principal Position	Year		Salary ($)		Bonus ($)		Stock Awards ($)(1)			Option Awards ($)(2)		All Other Compensation ($)(3)		Total ($)
Bradley L. Hansen		2018		300,000		-		496,000			-		33,320		829,320
President and Chief Executive Officer		2017		300,000		-		1,380,000	⁽⁴⁾		-		39,817		1,719,817
Daniel A. Nordloh		2018		215,000		21,500		109,800			36,126		18,197		400,623
Executive Vice President of Global Business Development		2017		215,000		21,500		-			-		15,448		251,948
Kevin A. Dennis		2018		215,000		17,200		109,800			36,126		7,567		385,693
Vice President of Engineering and Product Development

(1)

The amounts shown in this column indicate the full grant date fair value of restricted stock unit awards (“RSUs”) computed in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718 (“FASB ASC Topic 718”), excluding the effect of the forfeitures. For additional information regarding the assumptions made in calculating these amounts, see the Notes to our consolidated financial statements included in our Annual Report on Form 10-K. These amounts reflect our accounting expense for these awards and do not correspond to the actual value that will be recognized by the named executive officers.

(2)

The amounts shown in this column indicate the full grant date fair value of option awards computed in accordance with FASB ASC Topic 718. Generally, the full grant date fair value is the amount that we would expense in our financial statements over the award’s vesting schedule. For additional information regarding the assumptions made in calculating these amounts, see the Notes to our consolidated financial statements included in our Annual Report on Form 10-K. These amounts reflect our accounting expense for these awards and do not correspond to the actual value that will be recognized by the named executive officers.

(3)

The amounts set forth in this column consisted of (i) matching contributions to our 401(k) Plan, (ii) car allowance and commuting expense reimbursement and (iii) apartment lease reimbursement as follows:

	Year		Matching Contribution to 401(k) Plan ($)		Commuting Expense Reimbursement ($)		Apartment Lease Reimbursement		Total ($)
Bradley L. Hansen		2018		-		9,200		24,120		33,320
		2017		-		8,122		31,695		39,817
Daniel A. Nordloh		2018		9,460		8,737		-		18,197
		2017		7,950		7,498		-		15,448
Kevin A. Dennis		2018		7,567		-		-		7,567

(4)

Includes the grant date value of a time-based restricted stock unit award ($742,500) and the incremental grant date value associated with certain modifications made to the performance-based conditions associated with a previously award restricted stock unit award ($637,500), in each case computed in accordance with FASB ASC Topic 718. The performance conditions associated with this performance-based award were not satisfied as a result of which none of this award will be earned by the executive.

Outstanding Equity Awards at June 30, 2018

The following table presents information about unexercised options that were held by the named executive officers as of June 30, 2018.

	Options Awards											Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable			Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)		Option Exercise Price ($)		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)			Market Value of Shares or Units of Stock That Have Not Vested ($)(1)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#)			Equity Incentive Plan Awards: Market Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(1)
Bradley L. Hansen		360,000		-			-		1.72		05/19/22		250,000	⁽²⁾		92,500		500,000	⁽⁵⁾		185,000
													500,000	⁽³⁾		185,000		100,000	⁽⁶⁾		37,000
													500,000	⁽⁴⁾		185,000
Daniel A. Nordloh		-		120,000	⁽⁷⁾		-		0.41		12/19/25							180,000	⁽⁵⁾		66,600
		240,000		120,000	⁽⁸⁾		-		0.37		06/28/24							100,000	⁽⁶⁾		37,000
		240,000		120,000	⁽⁹⁾		-		0.76		08/11/23
		48,000		-			72,000		1.02		09/16/22
		6,000		-			14,000		0.78		11/05/21
		4,000		-			-		1.90		09/06/20
		8,000		-			-		3.80		01/11/20
		5,000		-			-		4.55		08/29/19
Kevin A. Dennis		-		120,000	⁽⁷⁾		-		0.41		12/19/25							180,000	⁽⁵⁾		66,600
		240,000		120,000	⁽⁸⁾		-		0.37		06/28/24							100,000	⁽⁶⁾		37,000
		240,000		120,000	⁽⁹⁾		-		0.76		08/11/23
		59,748		-			60,000		0.48		12/11/22
		25,000		-			25,000		0.78		11/05/21
		18,000		-			-		1.90		09/06/20
		8,000		-			-		3.80		01/11/20

(1)

The market value of shares of restricted stock units is based on the closing price of our common stock on June 30, 2018 ($0.37).

(2)

Represents the unvested portion of a restricted stock unit award that vests on November 17, 2018.

(3)

Represents the unvested portion of a restricted stock unit award that vests in two equal annual installments on November 14, 2018 and November 14, 2019.

(4)

Represents the unvested portion of a restricted stock unit award that vests in three equal annual installments beginning on December 21, 2018.

(5)

Represents the unearned portion of performance-based RSUs, one third of which will vest for any calendar quarter between January 1, 2018 and December 31, 2020 that the Company achieves positive earnings before interest, taxes, depreciation, amortization and stock-based compensation expense (“EBITDAS”). In accordance with SEC rules, the amounts represent the maximum amounts payable in connection with such RSU awards.

(6)

Represents the unearned portion of performance-based RSUs, 100% of which will vest if the Company achieves positive EBITDAS for the quarter ended June 30, 2019. In accordance with SEC rules, the amounts represent the maximum amounts payable in connection with such RSU awards.

(7)

Represents the unvested portion of an option grant which vests in three equal annual installments beginning on December 19, 2018.

(8)

Represents the unvested portion of an option grant which vests on June 28, 2019.

(9)

Represents the unvested portion of an option grant which vests on August 11, 2018.

Employment Agreements

On May 19, 2014, Bradley L. Hansen entered into an employment agreement with us as our President and Chief Operating Officer and as a member of our Board of Directors which provides for a minimum base salary of $245,000.

Mr. Hansen’s employment agreement was amended on July 13, 2015 in connection with his appointment as Chief Executive Officer to increase his annual salary to $300,000 per year and extend the initial term until June 30, 2019.

If we terminate Mr. Hansen’s employment agreement for any reason other than for Cause or Disability (each as defined in the employment agreement) or Mr. Hansen terminates his employment for Good Reason (as defined in the employment agreement), or he dies, we must pay him a severance payment in an amount equal to the greater of (i) six months of his annual base salary as then in effect and (ii) payment of his base salary as then in effect for the remainder of the Term (as defined in the employment agreement), and he is entitled to certain benefits under COBRA. If his employment agreement is terminated for Disability, Mr. Hansen will be entitled to a severance payment in an amount equal to six months of his annual base salary as then in effect. Furthermore, Mr. Hansen will forfeit any options that have not vested at the time of termination for any reason, except that upon a change of control, the options shall become immediately exercisable and fully vested.

On September 30, 2014, Daniel A. Nordloh entered into an amended and restated employment agreement with us to act as our Executive Vice President of Global Business Development and pursuant to which he is being paid a salary of $215,000.

If we terminate Mr. Nordloh’s employment agreement for any reason other than Cause or Disability (each as defined in the employment agreement) or Mr. Nordloh terminates his employment for Good Reason (as defined in the employment agreement) or Mr. Nordloh dies, we must pay him a severance payment in an amount equal to three months of his annual base salary as then in effect, and he is entitled to certain benefits under COBRA. If we terminate Mr. Nordloh’s employment agreement for Disability, we must pay him a severance payment in an amount equal to three months of his base salary as then in effect, and he is entitled to certain benefits under COBRA.

On September 30, 2014, Kevin A. Dennis entered into an amended and restated employment agreement to act as our Vice President of Engineering and Product Development and pursuant to which he is being paid a salary of $215,000.

If we terminate Mr. Dennis’ employment agreement for any reason other than Cause or Disability (each as defined in the employment agreement) or Mr. Dennis terminates his employment for Good Reason (as defined in the employment agreement) or Mr. Dennis dies, we must pay him a severance payment in an amount equal to six months of his annual base salary as then in effect, and he is entitled to certain benefits under COBRA. If we terminate Mr. Dennis’ employment agreement for Disability, we must pay him a severance payment in an amount equal to three months of his base salary as then in effect, and he is entitled to certain benefits under COBRA.

Director Compensation

2018 Compensation Policy for Non-Employee Directors

On November 14, 2017, the Board of Directors adopted the following compensation policy for members of the Board of Directors who are not officers or employees of the Company or any subsidiary of the Company (“non-employee directors”):

An annual equity retainer in the amount of $96,000, payable as follows. The annual equity retainer for a non-employee director for a year will be awarded as of the date of the annual meeting of shareholders of the Company (the “Annual Meeting”) in the form of RSUs under the Company’s 2012 Non-Employee Director Equity Compensation Plan (or any successor plan thereto) (the “2012 Director Equity Plan”). The RSUs will have the following terms and conditions: (A) the number of RSUs is determined by dividing the dollar amount of the award by the closing price of the Company’s common stock on the first business day preceding the Annual Meeting, rounded up to the next whole share; (B) 25% of the RSUs vest on the date of grant, and the remaining RSUs vest 25% each on March 31, June 30 and September 30 following the Annual Meeting, provided the non-employee director remains in continuous service with the Board of Directors through the applicable vesting date; (C) the RSUs vest earlier in the event of a “Change in Control” of the Company (as defined in the 2012 Director Equity Plan); (D) except in the case of Mr. Stern’s RSUs, vested RSUs are payable upon the earlier of (x) the date that is 90 days after the non-employee director “separates from service” with the Board of Directors (within the meaning of Section 409A of the Internal Revenue Code) or (y) the date of a Change in Control (provided that the Change in Control is a permissible “change in control” payment event within the meaning of Section 409A of the Internal Revenue Code); (E) Mr. Stern’s vested RSUs are payable on vesting; (F) vested RSUs are payable in the form of one share of common stock of the Company for each vested RSU then payable; and (G) the RSUs will otherwise be subject to the terms of the 2012 Director Equity Plan and will be evidenced by an appropriate RSU award agreement.

In addition, an annual Chairman’s retainer in the following amounts, payable in cash quarterly in arrears: $50,000 for the Chairman of the Board of Directors; $12,000 for the Chairman of the Audit Committee and for the Chairman of the Compensation Committee; and $8,000 for the Chairman of the Nominating and Governance Committee.

In addition, an annual committee membership fee in the amount of $6,000 for each committee of the Board of Directors on which the non-employee director serves, payable in cash quarterly in arrears, provided the non-employee director remains in continuous service with the Board of Directors through each applicable payment date.

Directors who are not non-employee directors receive no compensation for such service.

To preserve Company cash, (1) in June 2018, the Board of Directors modified the policy so that the cash fees payable for the fourth quarter of fiscal 2018 were paid in fully vested RSUs and (2) in September 2018, the Board of Directors modified the policy so that the cash fees payable for the first quarter of fiscal 2019 were paid in fully vested RSUs. In September 2018, the Board of Directors also modified the director compensation policy to reduce the annual equity retainer to from $96,000 to $72,000.

Non-Employee Director Compensation in 2018

The following table provides compensation information for the one-year period ended June 30, 2018 for each non-employee member of our Board of Directors.

Name	Fees Earned or Paid in Cash ($)		Stock Awards ($)(1)(2)
Richard A. Abdoo		25,500		102,500
Eric C. Apfelbach ⁽³⁾		6,000		-
Manfred E. Birnbaum		28,500		103,500
Hoong Khoeng Cheong ⁽⁴⁾		6,000		-
Paul F. Koeppe		57,000		113,000
James H. Ozanne		28,500		103,500
Theodore Stern		19,500		100,500

(1)

The amounts shown in this column indicate the full grant date fair value of restricted stock unit or option awards, respectively, awards computed in accordance with FASB ASC Topic 718. Generally, the full grant date fair value is the amount that we would expense in our financial statements over the award’s vesting schedule. For additional information regarding the assumptions made in calculating these amounts, see the Notes to our consolidated financial statements included in our Annual Report on Form 10-K. These amounts reflect our accounting expense for these awards and do not correspond to the actual value that will be recognized by the directors. The amounts in this column include the grant date fair value of restricted stock awards granted to certain non-employee directors on June 26, 2018 in lieu of cash they would otherwise be due for the quarter needed June 30, 2018.

(2)

The aggregate number of restricted stock unit awards and option awards outstanding on June 30, 2018 and held by each non-employee director was as follows:

Name	Number of Securities Underlying Unexercised Options		Number of Securities Underlying Restricted Stock Unit Awards
Richard A. Abdoo		-		787,082
Eric C. Apfelbach		-		-
Manfred E. Birnbaum		-		374,553
Hoong Khoeng Cheong		-		-
Paul F. Koeppe		40,000		854,662
James H. Ozanne		15,000		736,727
Theodore Stern		15,000		274,293

(3)

Mr. Apfelbach resigned from the Board of Directors effective September 27, 2017.

(4)

Mr. Cheong’s term as a member of the Board of Directors expired effective December 19, 2017.

EQUITY COMPENSATION PLAN INFORMATION

We maintain the following equity compensation plan under which our equity securities are authorized for issuance to our employees and/or directors: the 2010 Omnibus Long-Term Incentive Plan; and the 2012 Non-Employee Director Equity Compensation Plan. We also maintain the following three equity compensation plans, which are frozen and under which no new grants will be made: the 2002 Stock Option Plan, the Employee Stock Option Scheme, and the 2007 Equity Incentive Plan. Each of the foregoing equity compensation plans was approved by our shareholders. The following table presents information about these plans as of June 30, 2018.

Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights			Weighted average exercise price of outstanding options, warrants and rights			Number of securities remaining available for future issuance under equity compensation plans (excluding securities outstanding)

Equity compensation plans approved by security holders		13,400,283	⁽¹⁾	$	0.60	⁽²⁾		3,427,344	⁽³⁾

Equity compensation plans not approved by security holders		1,185,000	⁽⁴⁾	$	1.10			None

Total		14,585,283		$	0.65			3,427,344

(1)

Includes 7,260,468 outstanding restricted stock units under plans approved by our security holders.

(2)

Does not reflect restricted stock units included in the first column that do not have an exercise price.

(3)

Represents shares available for issuance under our 2010 Omnibus Long-term Incentive Plan and 2012 Non-Employee Director Equity Compensation Plan.

(4)

Consists of inducement option grants awarded to members of management of Tier Electronics LLC in connection with its acquisition in January 2011, Mr. Hansen in connection with his hiring in May 2014, and certain other non-executives in connection with their hiring in 2017. In connection with our acquisition of Tier Electronics LLC in January 2011 we issued inducement option grants to purchase a total of 150,000 shares of common stock at an exercise price of $5.75 of which 5,000 remained outstanding at June 30, 2018. In connection with his appointment as President and Chief Operating Officer in May 2014, we awarded Mr. Hansen an inducement option grant to purchase 360,000 shares of common stock at an exercise price of $1.72 subject to certain time-based vesting requirements. Also in connection with his appointment as President and Chief Operating Officer in May 2014, we awarded Mr. Hansen an inducement restricted stock unit award covering a total of 360,000 shares of common stock subject to certain performance-based vesting requirements, of which 270,000 of such restricted units were vested and earned in September 2015. In January and February 2017 we awarded a total of 270,000 inducement option grants to three non-executive employees subject to certain time-based vesting requirements of which 90,000 remained outstanding at June 30, 2018. In connection with the appointment of Mr. Dallapiazza as Chief Financial Officer in February 2018, we awarded Mr. Dallapiazza an inducement option grant to purchase 120,000 shares of common stock at an exercise price of $0.37 subject to certain time-based vesting requirements and inducement restricted stock unit award covering a total of 180,000 shares of common stock subject to certain performance-based vesting requirements. In April 2018 we awarded a total of 160,000 inducement option grants to two non-executive employees subject to certain time-based vesting requirements.

PROPOSAL 2 – ADVISORY VOTE ON EXECUTIVE COMPENSATION

The Proposal

We are providing our shareholders with the opportunity to express their views on our named executive officers’ compensation by casting their vote on this Proposal 2. This non-binding, advisory vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers as described in this proxy statement.

At our annual meeting of shareholders for 2017, 59.9% of the votes cast on the non-binding, advisory vote to approve the compensation of our named executive officers were voted in favor of the proposal. The compensation committee believes this affirms the shareholders’ support of our approach to executive compensation.

Our executive compensation program, which is described in detail in the “Executive and Director Compensation” section, is intended to offer our executive officers compensation and benefits that are competitive and meet our goals of attracting, retaining and motivating highly skilled management, which is necessary to achieve our financial and strategic objectives and create long-term value for our shareholders. We believe that our executive compensation program accomplishes these goals in a way that is consistent with our purpose and core values and the long-term interests of the Company and its shareholders.

Although the vote on this Proposal 2 regarding the compensation of our named executive officers is not binding, we value the opinions of our shareholders and will consider the result of the vote when determining future executive compensation arrangements.

If this proposal is approved, our shareholders will be approving the following resolution:

RESOLVED, that the compensation paid to the Company’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K in the Company’s proxy statement for the 2018 Annual Meeting of Shareholders, is hereby approved.

Vote Required for Approval

The affirmative vote of a majority of the total votes cast on the foregoing resolution by the holders of our common stock and series B convertible preferred stock, voting together on a combined basis, is required to approve, on an advisory basis, such resolution. Abstentions and broker non-votes will have no effect on the outcome of the proposal.

Board Recommendation

The Board of Directors recommends a vote “ FOR ” this Proposal 2.

PROPOSAL 3—APPROVAL OF AMENDMENT NO. 6 TO
ENSYNC, INC. 2010 OMNIBUS LONG-TERM INCENTIVE PLAN

General

On August 26, 2010, our Board of Directors originally adopted the 2010 Omnibus Long-Term Incentive Plan, and the plan became effective upon approval by our shareholders on November 10, 2010 (the “Omnibus Plan”). The Omnibus Plan has been amended by that certain Amendment No. 1 approved by our shareholders at their Annual Meeting on November 7, 2012; Amendment No. 2 approved by our shareholders at their Annual Meeting on November 18, 2014; Amendment No. 3 approved by our shareholders at their Annual Meeting on November 17, 2015; Amendment No. 4 approved by our shareholders at their Annual Meeting on November 14, 2016; and Amendment No. 5 approved by our shareholders at their Annual Meeting on December 19, 2017. As of September 27, 2018, approximately 1,350,217 shares remained available for issuance under the Omnibus Plan. Our Board of Directors has determined that this remaining amount is insufficient to meet the Company’s equity compensation requirements on a going forward basis.

On September 27, 2018, our Board of Directors approved Amendment No. 6 of the Omnibus Plan, described in this proposal (the “Omnibus Plan Amendment”), subject to shareholder approval. If approved by our shareholders, the Omnibus Plan Amendment will increase the number of shares available for issuance under the Omnibus Plan by 5,000,000 shares.

A copy of the Omnibus Plan Amendment is attached as Appendix A to this Proxy Statement. The material terms of the Omnibus Plan, assuming the approval of the Omnibus Plan Amendment, are summarized below under the heading “Material Features of the Omnibus Plan.” This summary of the Omnibus Plan is not intended to be a complete description of the Omnibus Plan and is qualified in its entirety by the actual text of the Omnibus Plan, which is attached as Appendix A to the Company’s proxy statement for our 2010 Annual Meeting of Shareholders, filed with the SEC on September 24, 2010; Appendix A to the Company’s proxy statement for our 2012 Annual Meeting of Shareholders, filed with the SEC on September 25, 2012; Appendix A to the Company’s proxy statement for our 2014 Annual Meeting of Shareholders, filed with the SEC on October 9, 2014; Appendix B to the Company’s proxy statement for our 2015 Annual Meeting of Shareholders, filed with the SEC on October 7, 2015; Appendix A to the Company’s proxy statement for our 2016 Annual Meeting of Shareholders, filed with the SEC on October 11, 2016 and Appendix A to the Company’s proxy statement for our 2017 Annual Meeting of Shareholders, filed with the SEC on October 5, 2017.

Reasons for the Amendment

The purpose of the Omnibus Plan Amendment is to provide the Company with sufficient flexibility to continue to use the Omnibus Plan to further the Company’s compensation philosophy and programs. Our Board of Directors believes that the interests of the Company and our shareholders will be advanced if we can continue to offer our officers, non-employee directors, key employees, consultants and advisors the opportunity to acquire or increase a direct ownership interest in the operations and future success of the Company. In addition, the ability to obtain and retain new quality personnel by offering competitive compensation is of great importance to the success of the Company. However, our Board of Directors has determined that the current number of shares authorized for issuance under the Omnibus Plan is insufficient for the stated objectives of the Omnibus Plan. The Omnibus Plan Amendment will increase the number of shares available for issuance under the Omnibus Plan by 5,000,000 shares.

Material Features of the Omnibus Plan

Administration of the Plan

Our Board of Directors has such powers and authorities related to the administration of the Omnibus Plan as are consistent with our corporate governance documents and applicable law. Pursuant to its charter, the Omnibus Plan is administered by our Compensation Committee (the “Administrator”).

Type of Awards

The following types of awards are available for grant under the Omnibus Plan: incentive stock options (“ISOs”), nonqualified stock options (“NSOs”), stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), cash- or stock-based performance awards and other stock-based awards.

Number of Authorized Shares

If shareholders approve the Omnibus Plan Amendment, subject to adjustment (in connection with certain changes in capitalization), the total number of shares of our common stock that will be reserved for issuance under the Omnibus Plan will be 16,255,229, all of which will be available for issuance under ISOs.

Subject to adjustment in connection with certain changes in capitalization: the maximum number of stock options and SARs in the aggregate that may be granted to any grantee in any 12-month period will be 6,000,000; and the maximum number of shares with respect to stock-based performance awards (other than stock options and SARs) that are intended to qualify as “performance-based compensation” under Code Section 162(m) (“Section 162(m)”) that may be granted to any grantee in any 12-month period will be 9,000,000. See below under “ Cash- and Stock-Based Performance Awards ” for more information on Section 162(m).

Non-Employee Director Award Limits

The maximum value of awards under the Omnibus Plan granted during any calendar year to any non-employee director, taken together with any cash fees paid to the director during the calendar year and the value of awards granted to the director under any other equity compensation plan of the Company or an affiliate during the calendar year, may not exceed the following in total value (calculating the value of any equity compensation plan awards based on the grant date fair value for financial reporting purposes): (i) $500,000 for the Chair of our Board of Directors and (ii) $350,000 for each non-employee director other than the Chair, except that awards granted to directors upon their initial election to our Board of Directors or the board of directors of an affiliate will not be counted towards these limits.

Share Counting

Shares underlying any outstanding stock options or other awards granted under our 2007 Equity Incentive Plan (formerly known as the ZBB Energy Corporation 2007 Equity Incentive Plan) or any other predecessor equity compensation plan of the Company that are forfeited, terminated or cancelled for any reason without issuance will again be available for the grant of new awards under the Omnibus Plan. If any award under the Omnibus Plan expires, or is terminated, surrendered or forfeited, in whole or in part, or the shares are not delivered because the award is settled in cash or used to satisfy the applicable tax withholding obligations, the unissued shares covered by such award will again be available for the grant of awards under the Omnibus Plan. If shares issued pursuant to the Omnibus Plan are repurchased by or are surrendered or forfeited to the Company at no more than cost, such shares will again be available for the grant of awards under the Omnibus Plan. In addition, any substitute award will not be counted against the number of shares reserved under the Omnibus Plan.

Eligibility and Participation

Eligibility to participate in the Omnibus Plan is limited to such employees, officers, non-employee directors, consultants and advisors of the Company, or of any affiliate, as the Administrator may determine and designate from time to time. As of September 27, 2018, approximately 49 non-executive officer employees, 4 executive officers, 5 non-employee directors and 4 consultants would have been eligible to receive awards under the Omnibus Plan.

New Plan Benefits

The benefits that will be awarded or paid under the Omnibus Plan (as amended by the Omnibus Plan Amendment) cannot currently be determined. Awards granted under the Omnibus Plan are within the discretion of our Compensation Committee, and the committee has not determined future awards or who might receive them.

Stock Options and SARs

Grants of Stock Options and SARs. The Administrator may award ISOs, NSOs and SARs to grantees under the Omnibus Plan. SARs may be awarded either in tandem with or as a component of other awards or alone.

Exercise Price of Stock Options and SARs. The exercise price per share of a stock option will be at least 100% of the fair market value per share underlying the award on the grant date. A SAR will confer on the grantee a right to receive, upon exercise, a payment of the excess of (1) the fair market value of one share on the date of exercise over (2) the grant price of the SAR as determined by the Administrator. The grant price will be fixed at the fair market value of a share on the grant date. SARs granted in tandem with an outstanding stock option following the grant date of such option will have a grant price that is equal to the option’s exercise price, except that the SAR’s grant price may not be less than the fair market value of a share on the grant date of the SAR.

Vesting of Stock Options and SARs. The Administrator will determine the terms and conditions (including any performance requirements) under which a stock option or SAR will become exercisable and will include such information in the award agreement.

Special Limitations on ISOs. In the case of a grant of a stock option intended to qualify as an ISO to a grantee that owns more than 10% of the total combined voting power of all classes of our outstanding shares (a “10% Shareholder”), the exercise price of the stock option will not be less than 110% of the fair market value of a share on the grant date. Additionally, a stock option will constitute an ISO only (1) if the grantee is an employee of the Company or a subsidiary of the Company, (2) to the extent such stock option is specifically designated as an ISO in the related award agreement, and (3) to the extent that the aggregate fair market value (determined at the time the stock option is granted) of the shares with respect to which all ISOs held by such grantee become exercisable for the first time during any calendar year (under the Omnibus Plan and all other plans of the grantee’s employer and its affiliates) does not exceed $100,000.

Exercise of Stock Options and SARs. A stock option may be exercised by the delivery to us of written notice of exercise and payment in full of the exercise price plus the amount of any taxes that we may be required to withhold. The Administrator has the discretion to determine the method or methods by which a SAR may be exercised.

Expiration of Stock Options and SARs. Stock options and SARs will expire at such times as the Administrator determines. However, no stock option may be exercised more than 10 years from the grant date, or in the case of an ISO held by a 10% Shareholder, more than five years from the grant date.

Restricted Stock and RSUs

Restricted Stock. At the time a grant of restricted stock is made, the Administrator may establish the applicable “restricted period” and prescribe restrictions in addition to or other than the expiration of the restricted period, including the satisfaction of corporate or individual performance objectives. Unless the Administrator otherwise provides in an award agreement, holders of restricted stock will have the right to vote such stock and the right to receive any dividends declared or paid with respect to such stock. The Administrator may provide that any such dividends paid must be reinvested in shares, which may or may not be subject to the same vesting conditions and restrictions applicable to such restricted stock. All distributions, if any, received by a grantee with respect to restricted stock as a result of any stock split, stock dividend, combination of shares or other similar transaction will be subject to the restrictions applicable to the original grant.

The grantee will be required, to the extent required by applicable law, to purchase the restricted stock at a price equal to the greater of (1) the aggregate par value of the shares represented by such restricted stock or (2) the price, if any, specified in the award agreement relating to such restricted stock. If specified in the award agreement, the price may be deemed paid by services already rendered.

RSUs. An RSU is a bookkeeping entry representing the right of a grantee to receive a specified number of shares upon the satisfaction of specified award conditions. At the time a grant of RSUs is made, the Administrator may establish the applicable “restricted period” and prescribe restrictions in addition to or other than the expiration of the restricted period, including the satisfaction of corporate or individual performance objectives. RSUs will not confer shareholder rights to grantees. The Administrator may provide that the holder of RSUs will be entitled to receive dividend equivalent rights, which may be deemed reinvested in additional RSUs.

Cash- and Stock-Based Performance Awards

Under the Omnibus Plan the Administrator may grant performance awards under which the grantee’s ability to exercise or receive a grant or settlement of any award, and the timing thereof, may be subject to such performance conditions as may be specified by the Administrator. The Administrator may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance conditions, and may, subject to certain limitations in the case of a performance award intended to qualify as “performance-based compensation” under Section 162(m), exercise its discretion to reduce the amounts payable under any award subject to performance conditions.

We may intend that performance awards granted to persons who are designated by the Administrator as likely to be “Covered Employees” within the meaning of Section 162(m) will, if so designated by the Administrator, qualify as “performance-based compensation” within the meaning of Section 162(m). The Omnibus Plan gives us the ability to grant performance awards that may qualify as “performance-based compensation” under Section 162(m). The grant, exercise and/or settlement of such performance awards will be contingent upon achievement of pre-established performance goals that will consist of one or more business criteria and a targeted level or levels of performance with respect to each of such criterion. Performance goals will be objective and generally are intended to meet the requirements of Section 162(m). However, we also believe that it is important to preserve flexibility in administering compensation programs in a manner designed to promote varying corporate goals. Accordingly, we have not adopted a policy that all compensation must qualify as deductible under Section 162(m). Amounts awarded or paid under any of our compensation programs, including the Omnibus Plan, may not qualify as “performance-based compensation” that is excluded from the limitation on deductibility under Section 162(m).

Under the Omnibus Plan, the maximum amount of each cash-based performance award intended to qualify as “performance-based compensation” under Section 162(m) granted to a grantee in any 12-month period may not exceed $2,000,000.

One or more of the following business criteria for the Company will be used exclusively by the Administrator in establishing performance goals for such awards:

net sales;

revenue;

revenue growth or product revenue growth;

operating income (before or after taxes);

pre- or after-tax income (before or after allocation of corporate overhead and bonuses);

net earnings;

earnings per share;

net income (before or after taxes);

return on equity;

total shareholder return;

return on assets or net assets;

appreciation in and/or maintenance of, share price;

market share;

gross profits;

earnings (including earnings before taxes, earnings before interest and taxes or earnings before interest, taxes depreciation and amortization);

economic value-added models or equivalent metrics;

comparisons with various stock market indices;

reduction in costs;

cash flows or cash flows per share (before or after dividends);

return on capital (including return on total capital or return on invested capital);

cash flow return on investment;

improvement in or attainment of expense levels or working capital levels;

operating margins;

gross margins or cash margin;

year-end cash;

debt reductions;

shareholder equity;

implementation, completion or attainment of measurable objectives with respect to research, development, products or projects and recruiting and maintaining personnel; and

to the extent permitted by applicable law, any other business criteria as determined by the Administrator.

Other Stock-Based Awards

The Administrator may grant other stock-based awards, consisting of stock units or other awards, valued in whole or in part by reference to, or otherwise based upon, our Common Stock. The terms of such other stock-based awards will be set forth in the applicable award agreements.

Change in Control.

Subject to the requirements and limitations of Code Section 409A, the Administrator may provide for any one or more of the following in connection with a Change in Control (as defined in the Omnibus Plan):

The Administrator may provide in any award agreement or, in the event of a Change in Control, may take such actions as it deems appropriate, to provide for the acceleration of the exercisability, vesting and/or settlement in connection with the Change in Control of each or any outstanding award or portion thereof and shares acquired pursuant thereto upon such conditions, including termination of the grantee’s service prior to, upon or following the Change in Control, to such extent as the Administrator may determine.

In the event of a Change in Control, the surviving, continuing, successor or purchasing corporation, or other business entity or parent thereof (the “Acquiror”), may, without the consent of any grantee, either assume or continue the Company’s rights and obligations under each or any award or portion thereof outstanding immediately prior to the Change in Control or substitute for each or any such outstanding award or portion thereof a substantially equivalent award with respect to the Acquiror’s stock. The Administrator may determine that an award denominated in shares is deemed assumed if, following the Change in Control, the award confers the right to receive, subject to the terms and conditions of the Omnibus Plan and the applicable award agreement, for each share subject to the award immediately prior to the Change in Control, the consideration to which a holder of a share on the date of the Change in Control was entitled, but if such consideration is not solely common stock of the Acquiror, the Administrator may, with the consent of the Acquiror, provide for the consideration to be received upon the exercise or settlement of the award, for each share subject to the award, to consist solely of common stock of the Acquiror equal in fair market value to the per share consideration received by holders of stock pursuant to the Change in Control. If any portion of such consideration may be received by holders of stock pursuant to the Change in Control on a contingent or delayed basis, the Administrator may determine the fair market value per share as of the time of the Change in Control on the basis of the Administrator’s good faith estimate of the present value of the probable future payment of such consideration. Any award or portion thereof that is neither assumed nor continued by the Acquiror in connection with the Change in Control, nor exercised or settled as of the Change in Control, will terminate and cease to be outstanding upon the Change in Control.

The Administrator may, without the consent of any grantee, determine that upon the occurrence of a Change in Control each or any award or a portion thereof outstanding immediately prior to the Change in Control and not previously exercised or settled will be canceled in exchange for a payment with respect to each vested share (and each unvested share, if so determined by the Administrator) subject to the canceled award in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party to the Change in Control or (iii) other property that will be in an amount having a fair market value equal to the fair market value of the consideration to be paid per share in the Change in Control, reduced by the exercise or purchase price per share, if any, under the award. If any portion of such consideration may be received by holders of stock pursuant to the Change in Control on a contingent or delayed basis, the Administrator may determine such fair market value per share as of the time of the Change in Control on the basis of the Administrator’s good faith estimate of the present value of the probable future payment of such consideration and, if such determination is made by the Administrator, the amount of such payment (reduced by applicable withholding taxes, if any) will be paid to grantees in respect of the vested portions of their canceled awards as soon as practicable following the date of the Change in Control and in respect of the unvested portions of their canceled awards in accordance with the vesting schedules applicable to such awards.

Deferral Arrangements

The Administrator may permit or require the deferral of any award payment into a deferred compensation arrangement .

Nontransferability of Awards

Generally, during the lifetime of a grantee, only the grantee may exercise rights under the Omnibus Plan and no award will be assignable or transferable other than by will or laws of descent and distribution. If authorized in the award agreement, a grantee may transfer, not for value, all or part of an award (other than an ISO) to certain family members (including trusts and foundations for the benefit thereof). Neither restricted stock nor RSUs may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the restricted period or prior to the satisfaction of any other restrictions prescribed by the Administrator .

Separation from Service

The Administrator may provide in the applicable award agreements for actions that will be taken upon a grantee’s separation from service from the Company, including but not limited to, accelerated vesting or termination of awards .

Tax Withholding and Tax Offset Payments

We will have the right to deduct from payments of any kind otherwise due to a grantee any federal, state or local taxes of any kind required by law to be withheld with respect to the vesting of or other lapse of restrictions applicable to an award or upon the issuance of any shares upon the exercise of a stock option or pursuant to an award .

Term of Plan

The authority to make grants under the Omnibus Plan is scheduled to terminate on November 10, 2020 .

Amendment and Termination

The Administrator may, at any time and from time to time, amend, suspend or terminate the Omnibus Plan as to any shares as to which awards have not been made. An amendment will be contingent on approval of our shareholders to the extent stated by our Administrator, required by applicable law or required by applicable stock exchange listing requirements. No awards will be made after termination of the Omnibus Plan. No amendment, suspension or termination of the Omnibus Plan may, without the consent of the grantee, impair rights or obligations under any award previously awarded under the Omnibus Plan.

Clawback Policy

If any of the Company’s financial statements are required to be restated, the Company may recover all or a portion of any award made under the Omnibus Plan with respect to any fiscal year of the Company the results of which are negatively affected by the restatement. The amount to be recovered will be the amount by which the affected award exceeds the amount that would have been payable had the financial statements been initially filed as restated. In no event will the amount to be recovered by the Company be less than the amount required to be repaid or recovered as a matter of law.

Further, all awards, amounts or benefits received or outstanding under the Omnibus Plan will be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in accordance with the terms of any Company clawback or similar policy or any applicable law related to such actions, as may be in effect from time to time. A grantee’s acceptance of an award will be deemed to constitute the grantee’s acknowledgement of and consent to the Company’s application, implementation and enforcement of any applicable Company clawback or similar policy that may apply to the grantee, whether adopted prior to or following the grant date of the award, and any provision of applicable law relating to clawback, cancellation, recoupment, rescission, payback or reduction of compensation, and the grantee’s agreement that the Company may take such actions as may be necessary to effectuate any such policy or applicable law, without further consideration or action.

Federal Income Tax Consequences

The following contains only a general discussion of the potential United States federal income tax consequences to grantees and the Company under the Omnibus Plan as of the date of this proposal. State or local tax rules, and tax rules applicable in jurisdictions outside the United Sates, are not discussed. The federal income tax consequences relating to the Omnibus Plan are complex and are subject to change.

NSOs and SARs. No taxable income is reportable when a NSO or SAR is granted. Upon exercise, the grantee will have ordinary income equal to the fair market value of the underlying shares on the exercise date minus the exercise price. Any gain or loss upon the disposition of the shares received upon exercise will be capital gain or loss to the grantee (which can be short- or long-term gains or losses depending on how long the shares are held before sale) .

ISOs. No taxable income is reportable when an ISO is granted or exercised (except for grantees who are subject to the alternative minimum tax, who may be required to recognize income in the year in which the ISO is exercised). If the grantee exercises the ISO and then sells the underlying shares more than two years after the grant date and more than one year after the exercise date, the excess of the sale price over the exercise price will be taxed as long-term capital gain or loss. If the grantee exercises the ISO and sells the shares before the end of the two- or one-year holding periods, he or she will have ordinary income at the time of the sale equal to the fair market value of the shares on the exercise date (or the sale price, if less) minus the exercise price of the ISO .

Restricted Stock and RSUs. A grantee of restricted stock or RSUs will not have taxable income upon the grant unless, in the case of restricted stock, the grantee elects to be taxed at that time. Instead, the grantee will have ordinary income at the time of vesting and/or settlement equal to the fair market value on the vesting and/or settlement date of the shares (or cash) received minus any amount paid for the shares.

Cash- and Stock-Based Performance Awards and Other Stock-Based Awards. Typically, a grantee will not have taxable income upon the grant of cash or stock-based performance awards or other stock-based awards. Subsequently, when the conditions and requirements for the grants have been satisfied and the payment determined, any cash received and the fair market value of any shares received will constitute ordinary income to the grantee.

Tax Effect for the Company. We generally will receive a tax deduction for any ordinary income recognized by a grantee in respect of an award under the Omnibus Plan (for example, upon the exercise of a NSO). In the case of ISOs that meet the holding period requirements described above, the grantee will not recognize ordinary income; therefore, we will not receive a deduction.

Because we are a public company, special rules limit the deductibility of compensation paid to certain of our executive officers whose compensation is required to be reported annually in our proxy statement. Under Section 162(m), the annual compensation paid to each of these executives may not be deductible to the extent that it exceeds $1 million. The limitation on deductions does not apply, however, to qualified “performance-based compensation.” Certain awards under the Omnibus Plan, including stock options, SARs and cash- and stock-based performance awards, may qualify as “performance-based compensation” and, as such, would be exempt from the $1 million limitation on deductible compensation. We consider the impact of Section 162(m) when developing and implementing our executive compensation plans. We also believe that it is important to preserve flexibility in administering compensation programs in a manner designed to promote varying corporate goals. Accordingly, we have not adopted a policy that all compensation must qualify as deductible under Section 162(m). Amounts awarded or paid under any of our compensation programs, including the Omnibus Plan, may not qualify as “performance-based compensation” that is excluded from the limitation on deductibility under Section 162(m).

Vote Required for Approval

The affirmative vote of a majority of the total votes cast on the foregoing resolution by the holders of our common stock and series B convertible preferred stock, voting together on a combined basis, is required to approve the Omnibus Plan Amendment. Abstentions and broker non-votes will not be counted as voting and, therefore, will have no impact on the approval of the proposal.

Board Recommendation

Our Board of Directors recommends that our shareholders vote “FOR” approval of the Omnibus Plan Amendment.

PROPOSAL 4—APPROVAL OF AMENDMENT NO. 4 TO
ENSYNC, INC. 2012 NON-EMPLOYEE DIRECTOR EQUITY COMPENSATION PLAN

General

On September 6, 2012, our Board of Directors adopted the 2012 Non-Employee Director Equity Compensation Plan, as approved by the Company’s shareholders at their 2012 Annual Meeting of Shareholders on November 7, 2012, as amended by that certain Amendment No. 1 approved by the Company’s shareholders at their 2014 Annual Meeting of Shareholders on November 18, 2014;Amendment No. 2 approved by the Company’s shareholders at their 2015 Annual Meeting of Shareholders on November 17, 2015 and Amendment No. 3 approved by the Company’s shareholders at their 2016 Annual Meeting of Shareholders on November 14, 2016 (the “Director Equity Plan). As of September 27, 2018, approximately 298,375 shares remained available for issuance under the Director Equity Plan. Our Board of Directors has determined that this remaining amount is insufficient to meet the Company’s equity compensation requirements .

On September 27, 2018, our Board of Directors approved the amendment of the Director Equity Plan described in this proposal (the “Director Plan Amendment”), subject to shareholder approval. If approved by our shareholders, the Director Plan Amendment will increase the number of shares available for issuance under the Director Equity Plan by 2,000,000 shares.

A copy of the Director Plan Amendment is attached as Appendix B to this Proxy Statement. The material terms of the Director Equity Plan, assuming the approval of the Director Plan Amendment, are summarized below under the heading “Material Features of the Director Equity Plan.” This summary of the Director Equity Plan is not intended to be a complete description of the Director Equity Plan and is qualified in its entirety by the actual text of the Director Equity Plan, which is attached as Appendix B to the Company’s proxy statement for our 2012 Annual Meeting of Shareholders, filed with the SEC on September 25, 2012; Appendix C to the Company’s proxy statement for our 2015 Annual Meeting of Shareholders, filed with the SEC on October 7, 2015 and Appendix B to the Company’s proxy statement for our 2016 Annual Meeting of Shareholders, filed with the SEC on October 11, 2016.

Reasons for the Amendment

The purpose of the Director Plan Amendment is to provide the Company with sufficient flexibility to continue to use the Director Equity Plan to further the Company’s compensation philosophy and programs. Our Board of Directors believes that the interests of the Company and our shareholders will be advanced if we can continue to offer our non-employee directors RSU awards and the other types of awards as discussed below to help align the interests of our non-employee directors with those of our shareholders. However, our Board of Directors has determined that the current number of shares authorized for issuance under the Director Equity Plan is insufficient for the stated objectives of the plan. The Director Plan Amendment will increase the number of shares available for issuance under the Director Equity Plan by 2,000,000 shares.

Material Features of the Director Equity Plan

Administration of the Plan. Our Board of Directors has such powers and authorities related to the administration of the Director Equity Plan as are consistent with our corporate governance documents and applicable law. Our Board of Directors has the full power and authority to take all actions and to make all determinations required or provided for under the Director Equity Plan, any award or any award agreement, and has the full power and authority to take all such other actions and make all such other determinations not inconsistent with the specific terms and provisions of the Director Equity Plan that the Board of Directors deems to be necessary or appropriate to the administration of the plan.

Type of awards. Any type of award provided for in the Omnibus Plan is available for grant under the Director Equity Plan (except for ISOs). For information concerning the types of awards that may be made under the Director Equity Plan, see the section entitled “Material Features of the Omnibus Plan” under Proposal 3 above.

Number of Authorized Shares. If shareholders approve the Director Plan Amendment, subject to adjustment (in connection with certain changes in capitalization), the total number of shares of our common stock that will be reserved for issuance under the Director Equity Plan will be 5,194,051.

Annual Award Limits . The maximum value of awards under the Director Equity Plan granted during any calendar year to any director, taken together with any cash fees paid to the director during the calendar year and the value of awards granted to the director under any other equity compensation plan of the Company or an affiliate during the calendar year, may not exceed the following in total value (calculating the value of any equity compensation plan awards based on the grant date fair value for financial reporting purposes): (i) $500,000 for the Chair of our Board of Directors and (ii) $350,000 for each non-employee director other than the Chair, except that awards granted to directors upon their initial election to our Board of Directors or the board of directors of an affiliate will not be counted towards these limits.

Share Counting. If any award under the Director Equity Plan expires, or is terminated, surrendered or forfeited, in whole or in part, or the shares are not delivered because the award is settled in cash or used to satisfy the applicable tax withholding obligations, the unissued shares covered by such award will again be available for the grant of awards under the Director Equity Plan. If shares issued pursuant to the Director Equity Plan are repurchased by, or are surrendered or forfeited to the Company at no more than cost, such shares will again be available for the grant of awards under the Director Equity Plan.

Eligibility and Participation. Eligibility to participate in the Director Equity Plan is limited to those members of our Board of Directors who are not current employees of the Company or any of its subsidiaries. As of September 27, 2018, 6 directors were eligible to receive awards under the Director Equity Plan.

New Plan Benefits. We cannot currently determine the total benefits or number of shares subject to awards that may be granted in the future under the Director Equity Plan. However, as discussed above under “Non-employee Director Compensation” and in accordance with our Director Compensation Policy, if the Director Plan Amendment is approved by the shareholders we anticipate that on the date of our 2018 annual meeting our non-employee directors will receive RSUs as indicated in the following table:

New Plan Benefits
Dollar Value		Number of Units
$	288,000		960,000	(1)

(1)

Based on an assumed price of our common stock equal to $0.30 per share, which was the volume weighted average closing price of our common stock for the 20-trading day period ending September 27, 2018.

Federal Income Tax Consequences. For information concerning the federal income tax consequences associated with awards that may be made under the Director Equity Plan, see the section entitled “Federal Income Tax Consequences” under Proposal 3 above.

Change in Control. Subject to the requirements and limitations of Section 409A if applicable, our Board of Directors may provide for any one or more of the following in connection with a Change in Control (as defined in the Omnibus Plan):

Except as may be provided otherwise in the applicable award agreement, upon a Change in Control, all restrictions with respect to outstanding awards under the Director Equity Plan will lapse and such awards will become vested and non-forfeitable.

In the event of a Change in Control, the surviving, continuing, successor or purchasing corporation, or other business entity or parent thereof (the “Acquiror”), may, without the consent of any grantee, either assume or continue the Company’s rights and obligations under each or any award or portion thereof outstanding immediately prior to the Change in Control or substitute for each or any such outstanding award or portion thereof a substantially equivalent award with respect to the Acquiror’s stock. Our Board of Directors may determine that an award denominated in shares is deemed assumed if, following the Change in Control, the award confers the right to receive, subject to the terms and conditions of the Director Equity Plan and the applicable award agreement, for each share subject to the award immediately prior to the Change in Control, the consideration to which a holder of a share on the date of the Change in Control was entitled, but if such consideration is not solely common stock of the Acquiror, our Board of Directors may, with the consent of the Acquiror, provide for the consideration to be received upon the exercise or settlement of the award, for each share subject to the award, to consist solely of common stock of the Acquiror equal in fair market value to the per share consideration received by holders of stock pursuant to the Change in Control. If any portion of such consideration may be received by holders of stock pursuant to the Change in Control on a contingent or delayed basis, our Board of Directors may determine the fair market value per share as of the time of the Change in Control on the basis of the Board of Directors’ good faith estimate of the present value of the probable future payment of such consideration. Any award or portion thereof that is neither assumed nor continued by the Acquiror in connection with the Change in Control, nor exercised or settled as of the Change in Control, will terminate and cease to be outstanding upon the Change in Control .

Our Board of Directors may, without the consent of any grantee, determine that upon the occurrence of a Change in Control each or any award or a portion thereof outstanding immediately prior to the Change in Control and not previously exercised or settled will be canceled in exchange for a payment with respect to each vested share (and each unvested share, if so determined by the Board of Directors) subject to the canceled award in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party to the Change in Control or (iii) other property that will be in an amount having a fair market value equal to the fair market value of the consideration to be paid per share in the Change in Control, reduced by the exercise or purchase price per share, if any, under the award. If any portion of such consideration may be received by holders of stock pursuant to the Change in Control on a contingent or delayed basis, our Board of Directors may determine such fair market value per share as of the time of the Change in Control on the basis of the Board of Directors’ good faith estimate of the present value of the probable future payment of such consideration and, if such determination is made by the Board of Directors, the amount of such payment (reduced by applicable withholding taxes, if any) will be paid to grantees in respect of the vested portions of their canceled awards as soon as practicable following the date of the Change in Control and in respect of the unvested portions of their canceled awards in accordance with the vesting schedules applicable to such awards .

Deferral Arrangements. Our Board of Directors may permit or require the deferral of any award payment into a deferred compensation arrangement .

Nontransferability of Awards. Generally, during the lifetime of a grantee, only the grantee may exercise rights under the Director Equity Plan and no award will be assignable or transferable other than by will or laws of descent and distribution. If authorized in the award agreement, a grantee may transfer, not for value, all or part of an award to certain family members (including trusts and foundations for the benefit thereof). Neither restricted stock nor RSUs may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the restricted period or prior to the satisfaction of any other restrictions prescribed by our Board of Directors.

Separation from Service. Our Board of Directors may provide in the applicable award agreements for actions that will be taken upon a grantee’s separation from service from the Company, including but not limited to, accelerated vesting or termination of awards.

Tax Withholding and Tax Offset Payments. We will have the right to deduct from payments of any kind otherwise due to a grantee any federal, state or local taxes of any kind required by law to be withheld with respect to the vesting of or other lapse of restrictions applicable to an award or upon the issuance of any shares upon the exercise of a stock option or pursuant to an award.

Term of Plan. The authority to make grants under the Director Equity Plan is scheduled to terminate on November 7, 2022.

Vote Required for Approval

The affirmative vote of a majority of the total votes cast on the foregoing resolution by the holders of our common stock and series B convertible preferred stock, voting together on a combined basis, is required to approve the Director Plan Amendment. Abstentions and broker non-votes will not be counted as voting and, therefore, will have no impact on the approval of the proposal .

Board Recommendation

Our Board of Directors recommends that our shareholders vote “ FOR ” approval of the Director Plan Amendment .

PROPOSAL 5 —RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Proposal

The Audit Committee of the Board of Directors has appointed Baker Tilly as our independent registered public accounting firm for the fiscal year ending June 30, 2019. We are presenting this selection to our shareholders for ratification at the annual meeting.

A representative of Baker Tilly is expected to be present at the annual meeting. In addition to having the opportunity to make a statement, Baker Tilly’s representative will be available to respond to any appropriate questions.

If the shareholders do not ratify the appointment of Baker Tilly, the Audit Committee will take such action into account in reconsidering the appointment of our independent registered public accounting firm for fiscal 2019. Even if the selection is ratified, the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year.

Vote Required for Approval

The affirmative vote of a majority of the total votes cast on this proposal by the holders of our common stock and series B convertible preferred stock, voting together on a combined basis, shall constitute ratification of the selection of Baker Tilly as our independent registered public accounting firm for fiscal 2019. Abstentions will not be counted as voting and, therefore, will have no impact on the approval of the proposal. Broker non-votes are not expected not occur in connection with this proposal.

Board Recommendation

Our Board of Directors recommends that the shareholders vote “ FOR ” ratification of the appointment of Baker Tilly as our independent registered public accounting firm for 2019.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The following table sets forth the aggregate fees billed or expected to be billed by Baker Tilly for fiscal 2018 and fiscal 2017, for audit and non-audit services, including “out-of-pocket” expenses incurred in rendering these services. The nature of the services provided for each category is described in the following the tables.

Fee Category	2018		2017
Audit Fees (1)		166,000		184,225
Audit-Related Fees (2)		10,000		79,130
Tax Fees		-		-
All Other Fees		-		-
Total		176,000		263,355

(1)

Audit fees include fees for professional services and expenses associated with the audits of our consolidated annual statements, reviews of our consolidated financial statements included in our Form 10-Qs, consents and assistance with and review of documents filed with the SEC.

(2)

Audit-related fees include fees for professional services and expenses associated with the preparation of comfort letters.

Pre-Approval Policies and Procedures

The Audit Committee has adopted a policy that requires all services to be provided by the Company’s independent public accounting firm, including audit services and permitted non-audit services, be pre-approved by the Audit Committee. The Audit Committee approved all audit and permitted non-audit services provided by Baker Tilly during fiscal years 2017 and 2018.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

James Koeppe, the son of Paul Koeppe, our Chairman of the Board of Directors, is a Manager at the Company and previously served as a consultant to the Company. In fiscal 2018, for his services as an employee, James Koeppe received total compensation from the Company in the amount of $201,729, which included an award of stock options and restricted stock units with a grant date fair value of $27,094 and $47,150, respectively. In fiscal 2017, for his services as an employee of, and previously as a consultant to, the Company, James Koeppe received total compensation from the Company in the amount of $144,400, which included an award of stock options with a grant date fair value of $26,400.

Anhui Meineng Store Energy Co., Ltd. ("Meineng") was established in late 2011 to develop, produce, sell, distribute and service advanced storage batteries and power electronics in China. Meineng assembles and manufactures certain of the Company's products for sale in the power management industry on an exclusive basis in mainland China and on a non-exclusive basis in Hong Kong and Taiwan. Our investment in Meineng was made through ZBB PowerSav Holdings Limited ("Holdco"), a limited liability Hong Kong holding company, formed with PowerSav New Energy Holdings Limited. We own 60% of Holdco's equity interests. We have the right to appoint a majority of the members of the Board of Directors of Holdco and Holdco has the right to appoint a majority of the members of the Board of Directors of Meineng. Our indirect interest in Meineng is approximately 30%. Bradley L. Hansen, our President and Chief Executive Officer, has served as the Chief Executive Officer of Meineng since December 2011. Mr. Hansen owns an indirect 6% equity interest in Meineng.

Meineng manufactures certain products for EnSync pursuant to a supply agreement under which we pay Meineng 120% of its direct costs incurred in manufacturing such products. We had product purchases of $400,000 and $1.3 million from Meineng Energy during fiscal 2018 and fiscal 2017, respectively. We manufacture certain products for Meineng pursuant to a supply agreement under which Meineng pays us 120% of our direct costs incurred in manufacturing such products. We had product sales of $22,000 and $73,000 to Meineng Energy during fiscal 2018 and fiscal 2017, respectively. Pursuant to a management services agreement, it is contemplated that Holdco will provide certain management services to Meineng in exchange for a management services fee equal to five percent of Meineng’s net sales for the subsequent three years, provided the payment of such fees will terminate upon Meineng completing an initial public offering on a nationally recognized securities exchange. To date, no management service fee revenues have been recognized by Holdco.

On September 5, 2018, the Company entered into a Stock Purchase Agreement with certain investors providing for the sale of 11,334,616 shares of the Company’s common stock, par value $0.01 per share for an aggregate purchase price of approximately $2.9 million at a price per share of $0.26 (the “Registered Direct Offering”). Participants in the Registered Direct Offering included the Company’s directors Paul Koeppe, Richard Abdoo and Theodore Stern, who purchased $350,000, $200,000 and $50,000 worth of shares of the Company’s common stock, respectively.

HOUSEHOLDING OF ANNUAL MEETING MATERIALS

Some banks, brokers and other nominee record holders may be participating in the practice of “householding.” This means that only one copy of our annual report and proxy statement will be sent to shareholders who share the same last name and address. Householding is designed to reduce duplicate mailings and save significant printing and postage costs.

If you receive a household mailing this year and would like to receive additional copies of our annual report and/or proxy statement, please submit your request in writing to: EnSync, Inc., N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051, Attention: Secretary or by calling the Company at (262) 253-9800. Any shareholder who wants to receive separate copies of the proxy statement in the future, or who is currently receiving multiple copies and would like to receive only one copy for his or her household, should contact his or her bank, broker, or other nominee record holder.

SHAREHOLDER PROPOSALS

In accordance with our Bylaws, nominations, other than by or at the direction of the Board of Directors, of candidates for election as directors at the 2019 Annual Meeting of Shareholders must be received by us no earlier than June 16, 2019 and no later than August 15, 2019. Such nominations must also satisfy the other requirements for shareholders nominations set forth in our Bylaws.

To be considered for inclusion in the proxy statement solicited by the Board of Directors, shareholder proposals for consideration at the 2019 Annual Meeting of Shareholders, pursuant to Rule 14a-8 promulgated under the Exchange Act by the SEC, must be received by us at our principal executive offices by June 12, 2019. Such proposals must also satisfy the procedures set forth in Rule 14a-8 under the Exchange Act. Our Bylaws require shareholders who wish to make a proposal at the next annual meeting of our shareholders—other than one that will be included in our proxy statement—to notify us no later than August 15, 2019. Such proposals must also satisfy the other requirements for shareholders proposals set forth in our Bylaws.

Such nominations or proposals must be submitted to EnSync, Inc., N88 W13901 Main Street, Suite 200, Menomonee Falls, Wisconsin 53051, Attention: Secretary. To avoid disputes as to the date of receipt, it is suggested that any shareholder proposal be submitted by certified mail, return receipt requested.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires our officers and directors, and persons who beneficially own more than 10% of our outstanding common stock, to file initial reports of ownership with respect to our equity securities and reports of changes in such ownership with the SEC. Such persons are required by SEC rules to furnish us with all copies of Section 16(a) forms they file.

Based solely on our review of the copies of such forms received by us, we believe that during the year ended June 30, 2018, all filing requirements were timely satisfied.

EXPENSES AND SOLICITATION

The cost of solicitation of proxies will be borne by us, and in addition to soliciting shareholders by mail, our directors, officers and other employees may, without receiving additional compensation, solicit proxies personally or by telephone. Solicitation by our directors, officers and other employees may also be made of some of our shareholders in person or by mail, telephone or telegraph following the original solicitation. We may request banks, brokers and other custodians, nominees and fiduciaries to forward proxy soliciting materials to the owners of our stock held in their names and, if so, will reimburse such banks, brokers and other custodians, nominees and fiduciaries for their reasonable out-of-pocket costs incurred in connection with the distribution of such proxy materials. We have engaged Kingsdale Advisors Kingsdale as our shareholder advisor and proxy solicitation agent and will pay fees of approximately $10,500 plus certain out-of-pocket expenses, to Kingsdale to assist us with the solicitation of proxies.

OTHER BUSINESS

The Board of Directors knows of no business that will be presented for consideration at the annual meeting other than those items stated above. If any other business should come before the annual meeting, votes may be cast pursuant to proxies in respect to any such business in the best judgment of the person or persons acting under the proxies.

Appendix A

Amendment No. 6 of the

EnSync, Inc. 2010 Omnibus Long-Term Incentive Plan

This Amendment No. 6 (“Amendment”), dated September 24, 2018, of the 2010 Omnibus Long-Term Incentive Plan (the “Existing Plan”; as amended hereby, the “Plan”), of EnSync, Inc., a Wisconsin corporation (the “Company”), is made and adopted by the Company, subject to approval of the shareholders of the Company.

Statement of Purpose

The Existing Plan was originally approved by the Company’s Board of Directors (the “Board”) on August 26, 2010, and by its shareholders on November 10, 2010, and became effective on such date. The Existing Plan was previously amended pursuant to that certain Amendment No. 1, effective upon shareholder approval on November 7, 2012, that certain Amendment No. 2, effective upon shareholder approval on September 17, 2014, that certain Amendment No. 3, effective upon shareholder approval on September 17, 2015, that certain Amendment No. 4, effective upon shareholder approval on September 20, 2016 and that certain Amendment No. 5, effective upon shareholder approval on September 19, 2017. The Board may amend the Existing Plan at any time, pursuant to and subject to Section 5.2 of the Existing Plan, contingent on approval by the shareholders of the Company, if shareholder approval is required by applicable securities exchange rules or applicable law. The Board has determined that it is advisable and in the best interest of the Company to amend the Existing Plan to increase the number of shares of the Company’s common stock, par value $0.01, authorized for issuance under the Existing Plan by 5,000,000 shares, and to make the other changes to the Existing Plan described in this Amendment.

NOW, THEREFORE, the Existing Plan is hereby amended as follows, subject to approval by the shareholders of the Company:

1. Capitalized Terms . All capitalized terms used and not defined herein shall have the meanings given thereto in the Existing Plan.

2. Amendment of Section 4.1.1 of Existing Plan . Section 4.1.1 of the Existing Plan is hereby deleted in its entirety and replaced with the following:

“4.1.1. Shares Available for Issuance

Subject to adjustment under Section 15, the aggregate number of shares of Common Stock that may be issued pursuant to the Plan is the sum of (i) 11,255,229 plus (ii) effective upon September 24, 2018 (subject to shareholder approval), 5,000,000. All of the shares of Common Stock available for issuance under the Plan shall be available for issuance as Incentive Stock Options. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares, treasury shares or shares purchased on the open market or otherwise, all as determined by the Company from time to time.”

3. Reference to and Effect on the Plan . The Plan, as amended hereby, and all other documents, instruments and agreements executed and/or delivered in connection therewith, shall remain in full force and effect, and are hereby ratified and confirmed.

4. Governing Law . This Amendment shall be governed by and construed in accordance with the laws of the State of Wisconsin.

* * *

Effective this 24 ^th day of September 2018.

Appendix B

Amendment No. 4 of the

EnSync, Inc. 2012 Non-Employee Director Equity Compensation Plan

This Amendment No. 4 (“Amendment”), dated September 24, 2018, of the 2012 Non-Employee Director Equity Compensation Plan (the “Existing Plan”; as amended hereby, the “Plan”), of EnSync, Inc., a Wisconsin corporation (the “Company”), is made and adopted by the Company, subject to approval of the shareholders of the Company.

Statement of Purpose

The Existing Plan was originally approved by the Company’s Board of Directors (the “Board”) on September 6, 2012, and by its shareholders on November 7, 2012, and became effective on such date. The Existing Plan was previously amended pursuant to that certain Amendment No. 1, effective upon shareholder approval on September 17, 2014, that certain Amendment No. 2, effective upon shareholder approval on September 17, 2015 and that certain Amendment No. 3, effective upon shareholder approval on September 20, 2016. The Board may amend the Existing Plan at any time, pursuant to and subject to Section 5.2 of the Existing Plan, contingent on approval by the shareholders of the Company, if shareholder approval is required by applicable securities exchange rules or applicable law. The Board has determined that it is advisable and in the best interest of the Company to amend the Existing Plan to increase the number of shares of the Company’s common stock, par value $0.01, authorized for issuance under the Existing Plan by 2,000,000 shares, and to make the other changes to the Existing Plan described in this Amendment.

NOW, THEREFORE, the Existing Plan is hereby amended as follows, subject to approval by the shareholders of the Company:

1. Capitalized Terms . All capitalized terms used and not defined herein shall have the meanings given thereto in the Existing Plan.

2. Amendment of Section 4.1.1 of Existing Plan . Section 4.1.1 of the Existing Plan is hereby deleted in its entirety and replaced with the following:

“ 4.1. Authorized Number of Shares

4.1.1. Shares Available for Issuance

Subject to adjustment under Section 9, the aggregate number of shares of Common Stock that may be issued pursuant to the Plan is the sum of (i) 3,194,051 shares plus (ii) effective upon September 24, 2018 (subject to shareholder approval), 2,000,000 shares.

4. Governing Law . This Amendment shall be governed by and construed in accordance with the laws of the State of Wisconsin.

* * *

Effective this 24 ^th day of September 2018.